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ABSTRACT OF THE DISSERTATION 
MECHANISMS OF CHLOROPEROXIDASE-CATALYZED ENANTIOSELECTIVE 
REACTIONS AS PROBED BY SITE-DIRECTED MUTAGENESIS AND ISOTOPIC 
LABELING 
by 
Lin Jiang 
Florida International University, 2012 
Miami, Florida 
Professor Xiaotang Wang, Major Professor 
Chloroperoxidase (CPO) is a heme-containing glycoprotein secreted by the marine 
fungus Caldariomyces fumago. Chloroperoxidase contains one ferriprotoporphyrin IX 
prosthetic group per molecule and catalyzes a variety of reactions, such as halogenation, 
peroxidation and epoxidation. The versatile catalytic activities of CPO coupled with the 
increasing demands for chiral synthesis have attracted an escalating interest in 
understanding the mechanistic and structural properties of this enzyme.  
In order to better understand the mechanisms of CPO-catalyzed enantioselective 
reactions and to fine-tune the catalytic properties of chloroperoxidase, asparagine 74 
(N74) located in the narrow substrate access channel of CPO was replaced by a bulky, 
nonpolar valine and a polar glutamine using site-directed mutagenesis. The CPO N74 
mutants displayed significantly enhanced activity toward nonpolar substrates compared 
to wild-type CPO as a result of changes in space and polarity of the heme distal 
environment. More interestingly, N74 mutants showed dramatically decreased 
chlorination and catalase activity but significantly enhanced epoxidation activity as a 
vii 
 
consequence of improved kinetic perfection introduced by the mutation as reflected by 
the favorable changes in kcat and kcat/KM of these reactions. It is also noted that the N74V 
mutant is capable of decomposing cyanide, the most notorious poison for many 
hemoproteins, as judged by the unique binding behavior of N74V with potassium cyanide.  
Histidine 105 (H105) was replaced by a nonpolar amino acid alanine using site-
directed mutagenesis. The CPO H105 mutant (H105A) displayed dramatically decreased 
chlorination and catalase activity possibly because of the decreased polarity in the heme 
distal environment and loss of the hydrogen bonds between histidine 105 and glutamic 
acid 183. However, significantly increased enantioselectivity was observed for the 
epoxidation of bulky styrene derivatives. Furthermore, my study provides strong 
evidence for the proposed histidine/cysteine ligand switch in chloroperoxidase, providing 
experimental support for the structure of the 420-nm absorption maximum for a number 
of carbon monoxide complexes of heme-thiolate proteins. 
For the NMR study, [dCPO(heme)] was produced using 90% deuterated growth 
medium with excess heme precursors and [dCPO(Phe)] was grown in the same highly 
deuterated medium that had been supplemented with excess natural phenylalanine. To 
make complete heme proton assignments, NMR spectroscopy has been performed for 
high-resolution structural characterization of [dCPO(heme)] and [dCPO(Phe)] to achieve 
unambiguous and complete heme proton assignments, which also allows important amino 
acids close to the heme active center to be determined.  
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CHAPTER I 
INTRODUCTION 
1.1 Overview of hemoproteins 
Hemoproteins are one of the largest classes of metalloproteins and in most cases 
contain a unique prosthetic group of iron-protoporphyrin IX in the active site 
(Montellano 1987). Ferriprotoporphyrin IX is composed of four pyrrole rings joined by 
methyne bridges with a ferric iron at the center, replacing the two hydrogen atoms that 
are attached to the pyrrole nitrogens. The carbon atoms of the methene bridges are 
symbolized as α, β, γ, and δ characters (Dunford 1999). The eight side chains in the 
ferriprotoporphyrin IX are four methyl groups at the 1, 3, 5, and 8 positions, two vinyl 
groups at the 2 and 4 positions, and two propionate groups at the 6 and 7 positions. The 
structure of the six coordinated heme iron allows histidine, cysteine or other amino acids 
in the enzyme to serve as the fifth ligand and external substrates to covalently bind to the 
heme iron as the sixth ligand (Williams 1987; Bertini 1994; Lu 2009).  
There are four main types of heme prothetic groups that contain a planar iron-
tetrapyrrole ring system with different side chains (Figure 1.1). Heme a can function as 
a cofactor for the cytochrome aa3 in the respiratory protein cytochrome c oxidase 
(CcO). Heme b (ferriprotoporphyrin IX) is the most abundant and important prothetic 
group among these four heme species, since heme b serves as the catalytic center for 
chloroperoxidase, catalase, hemoglobin, myoglobin, heme peroxidases, b-type 
cytochromes, and cytochrome P450s. Heme c is the prosthetic group for the extensively 
studied c-type electron transfer cytochromes. Heme dl normally exists in the heme-
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containing nitrite reductases designated to carry out the reduction of nitrite (Silvestrini 
1994; Malatesta 1995; Scott 1996).  
Hemoproteins are involved in a wide range of biological processes and carry out 
many essential metabolic functions (Sono 1996; Dunford 1999). It is concluded that the 
type of heme groups and the amino acid arrangment around the central heme are 
important to direct the heme to a prescribed function specifically and efficiently. The 
most familiar category is oxygen transport proteins, which are multisubunit and 
circulating molecules that provide an efficient supply of oxygen to metabolically active 
metazoans, including hemoglobin and myoglobin. Cytochromes, another class of heme-
containing proteins, are generally found either as monomeric proteins or as subunits of 
bigger enzymatic complexes that function as parts of the active membrane and electron 
transfer components to catalyze redox reactions. In addition to these traditional heme-
containing proteins, a new class of hemoproteins termed the heme-based sensor proteins 
has been reported recently such as guanylyl cyclase, FixL, and CO-sensing 
transcriptional activator (CooA), in which the heme acts as a sensor of an effector 
molecule (Lippard 1994; Dunford 1999; Lu 2001).  
1.2 Imidazole- and thiolate-ligated hemoproteins 
Enzymatic functions of hemoproteins are significantly affected by the polarity of the 
heme binding site and axial coordination to the central iron, especially the nature of the 
proximal ligand attached to the heme. In most heme peroxidases, the proximal heme 
ligand is a histidine nitrogen, while in catalase, tyrosine oxygen serves as the fifth heme 
iron ligand (Frew 1984; Dunford 1999). However, in cytochromes P450 and CPO, 
the cysteine sulphor is involved in covalent binding to the heme iron (Moore 1990). 
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Fig 1.1 Structure of the iron protoporphyrin IX (Heme b) and its derivatives usually 
found in hemoproteins. 
 
  
  
  
  
A. Heme a B. Heme b 
C. Heme c D. Heme d1 
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Therefore, depending on the type of the proximal ligands bound to the heme iron, 
hemoproteins are separated into two different classes  (Frew 1984). The first one is the 
imidazole-ligated protein with an imidazole group from histidine as the proximal ligand, 
including myoglobin, horseradish peroxidase and cytochrome c peroxidase. The other 
class is the thiolate-ligated protein that uses cysteine as the fifth ligand. The heme thiolate 
proteins include chloroperoxidase, cytochrome P450 and nitric oxide synthase. The 
histidine-ligated proteins are able to bind dioxygen reversibly and carry out their specific 
functions depending on amino acids near the heme center. However, the heme-thiolate 
proteins normally function as enzymes that catalyze the breakage of the oxygen-oxygen 
bond (Li 1994; Lu 2001; Omura 2005). The explanation for the reactivity differences 
between the thiolate- and imidazole-ligated heme proteins is that the proximal thiolate is 
more electron rich and pushes electrons more strongly to the central iron, thus making it 
more powerful to catalyze the related cleavage of O-O bond (Auclair 2001; Omura 2005).  
The imidazole and thiolate ligated heme proteins also show dramatic differences in 
their spectral properties in their carbon monoxide complexes. When the proximal ligand 
is a histidine, the Soret absorption peak of the ferrous hemoprotein-CO complex is 
located at 420 nm (Choudhury and M. F. 1994). However, the proximal cysteine gives a 
Soret peak at 450 nm for the ferrous protein (Dawson 1988; Hofrichter 2006). Therefore, 
carbon monoxide is an efficient substrate to identify the proximal ligands of 
hemoproteins (Sono 1996; Ortiz de Montellano 1998; Omura 2005). 
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been confirmed to be a thiolate anion (Dawson 1976), but the P450-like “heme-binding 
region” has not been identified in CPO’s primary sequence (Fang 1986). 
The third and fourth members of the heme thiolate protein family are cystathionine 
β-synthase (H-450) and nitric oxide synthase (NOS) because their carbon monoxide 
bound spectrum show P450-type peaks at 450 nm  and 443 nm, respectively (Omura 
1984; White 1992). The heme-containing domains of H-450 and NOS elucidated in the 
1990s showed no sequence homology with cytochrome P450 enzymes, although the 
amino acid sequence of NOS structurally resembled cytochrome P450 reductase (Ishihara 
1990; Bredt 1991). 
In recent years, CooA of bacterium Rhodospirillum rubrum and heme-regulated 
eIF2α kinase of animals joined the heme thiolate protein family (Aono 1998; Igarawshi 
2004). The protein CooA is a carbon monoxide sensor and transcriptional regulator, 
which activates the expression of a variety of enzymes participating in the oxidation of 
carbon monoxide. Heme-regulated eIF2α kinase regulates protein synthesis in 
reticulocytes by phosphorylating eIF2α factor when activated by nitric oxide. Both CooA 
and heme-regulated eIF2α kinase employ a thiolate anion as the proximal ligand in the 
oxidized form, but the axial ligand of the heme prosthetic group can be displaced when 
the heme is reduced and bound to either carbon monoxide or nitric oxide (Aono 1998; 
Igarawshi 2004). 
1.4 Engineering of hemoproteins 
Well-studied hemoproteins are primary targets of enzyme engineering because of 
their distinct activities and versatile functions with almost the same heme prosthetic 
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group. For protein engineering, there are two basic methods: rational design and directed 
evolution (Lu 2009).  
In rational design, such as site-directed mutagenesis, replacement of specific amino 
acid in the sequence is carried out by examing the detailed structure of the target protein. 
Therefore, rational design is not applicable to some new proteins without detailed 
structural knowledge. Furthermore, it is very difficult to predict the results of certain 
mutations in the protein structure. Computational protein design is another rational 
method to pre-specify the structure by finding out the lowest energy to stabilize the 
structure of proteins. However, inaccuracy of the predicted protein structure is an 
apparent drawback for the application of computational protein design (Voigt 2001; 
Dantas 2003) .  
In directed evolution, random mutagenesis at a selected sequence region is carried 
out, which mimics natural evolution (Voigt 2001). The advantage of directed evolution 
technique is that it is applicable to all proteins without detailed structure. Also it is not 
necessary to predict the effects of random mutation. However, directed evolution requires 
large amounts of recombinant DNA for screening and is not applicable for some proteins 
(Antonini 1971; Dawson 1988; Adachi 1993). 
Hemoproteins have special structural components and binding properties around the 
heme prosthetic group, which give them the diversity of functions and unique 
spectroscopic characteristics. The unique identity in the proximal site and the catalytic 
residues in the distal heme pocket are two features that have led to extensive study of 
hemoproteins. The ultimate goal of these studies is to solve the structures of target 
proteins and to evaluate the functions of certain residues in enzyme catalysis. With 
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detailed crystallographic structures of hemoproteins, the site-directed mutagenesis 
technique has been widely used to study structural-functional relationships of target 
proteins and to explore more efficient catalytic enzymes (Frandsen 1994). Replacement 
of a certain amino acid in the heme proximal or distal site can greatly change the 
interaction of the enzyme with substrates and therefore affect the catalytic efficiency of 
the enzyme, which provides the chance to discover novel enzymes with improved 
properties (Dawson 1988; White 1992; Sigman 1999; Lu 2001; Denisov 2005; Lu 2009). 
The axial ligands play dominant roles in modulation of structure and functions of 
hemoproteins. Therefore, changing the axial ligand is apparently an effective way to 
redesign hemoproteins. For example, the bis-His cytochrome b5 (Sligar 1987) and 
cytochrome c3 (Dolla 1994) have been converted to His-Met cytochromes by the 
replacement of the proximal histidine ligand with a methionine, which resulted in a 160-
180 mV increase in the redox potential. Mutation of His to Cys in the proximal ligand of 
cytochrome c leads to a 650 mV decrease in the reduction potential, which is the largest 
decrease of reduction potentials from axial ligand mutations so far (Sorrell 1989). In 
addition, by replacing the Met ligand to a noncoordinationg amino acid such as Ala using 
site-directed mutagenesis, cytochrome c has been converted into an oxygen-binding 
protein, which possesses a similar substrate-binding site for dioxygen and other 
exogenous ligands like myoglobin (Lu 1993). Interestingly, redesign can also be done in 
the reverse direction. For example, myoglobin has been mutated to the bis-His 
cytochrome b5 when the distal valine was replaced by a histidine residue (Qin 1994). 
The proximal thiolate ligation from cysteine is essential for the reactivity and 
spectral characteristics of many enzymes such as cytochrome P450s, NOS, CPO and 
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CooA hemoproteins. To study the role of the thiolate ligation, the axial ligand histidine 
has been mutated to a cysteine in both human (Adachi 1993) and horse heart myoglobins 
(Hildebrand 1995). Simililarly, the proximal histidine to cysteine mutation was also 
successfully carried out in heme oxygenase (Liu 1999). In a redesign in the reverse 
direction to the above work, the proximal cysteine ligand in CPO (Yi 1999) and 
cytochrome P450 (Auclair 2001) was replaced by a histidine residue. However, mutation 
of the axial cysteine to histidine in cytochrome P450cam led to a decreased camphor 
oxidation rate, increased uncoupling rate, slower electron transfer rate and enhanced 
peroxidase activity. The results indicate that the function of the proximal cysteine is 
essential for electron transfer, protein folding, and substrate binding (Auclair 2001). 
1.5 Characterization of chloroperoxidase 
Among thiolate-ligated hemoproteins, chloroperoxidase is one of the most versatile 
enzymes in the heme peroxidase family. The enzyme was discovered several decades ago 
by Hager and coworkers in the marine fungus Calduriomyces fumago (Hager 1966). 
Chloroperoxidase is a glycosylated heme-containing protein with a molecular weight of 
42 kilodaltons (Morris 1966). The biological function of CPO has been postulated to 
catalyze the biosysthesis of antibiotic caldariomycin. 
As is the case for many other hemoproteins, the active center of CPO is composed of 
one protoporphyrin IX group. Although CPO is a member of the heme peroxidase family, 
the proximal ligand is cysteine, which is identical to that of cytochromes P450. 
Chloroperoxidase can catalyze a variety of reactions, such as halogenation, peroxidation, 
oxygen insertion reactions, and decomposition of hydrogen peroxide to oxygen and water. 
Importantly, CPO can catalyze the epoxidation of olefins with high stereoselectivity. On 
10 
 
the basis of these functions and properties, CPO has been considered as a potential 
candidate for industrial application. 
1.5 Structure of chloroperoxidase 
Chloroperoxidase has a single polypeptide chain composed of 299 amino acids 
folded into eight helical segments (Fig 1.3). Structurally CPO has been considered as a 
P450-peroxidase hybrid because of the cysteinate proximal ligand and the peroxide-
binding site in the distal heme environment. However, the catalytic diversity of CPO is 
derived from its unique active site, which is distinguished from cytochromes P450 and 
other peroxidases. In the distal pocket of CPO, a glutamic acid instead of a histidine 
residue is involved in catalysis and responsible for the cleavage of the O-O bond in the 
formation of Cpd I complex (Sundaramoorthy 1995; Wang 2003; Kuhnel 2006).  
The crystallographic structure of CPO was published in 1995 (Sundaramoorthy 
1995).  The prosthetic group of the CPO active site was revealed to be a high-spin 
protoporphyrin IX molecule. The iron atom is penta-coordinated to the four nitrogens of 
the pyrrole ring and ligated to the sulphur of cysteine residue instead of the imidazole 
group of histidine. The entire heme is sandwiched between the C-terminal and N-terminal 
helices and positioned on their surface. The complete structure of CPO is composed of 
eight α-helices, named A – H. The distal residues of CPO are located in helix F. On the 
proximal side, helix A is perpendicular to the heme plane and close to the N-terminal, 
which is quite different from other peroxidases and cytochrome P450s (CYP450s). The 
mechanism by which this arrangement affects the properties of CPO is still unknown 
(Kuhnel 2006). 
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physical dimensions (Fig 1.5). Most halide binding sites are located in the narrow 
channel, which indicates the access pathway for the halides to the active oxoferryl center.  
 
Fig 1.5 Slice through a surface representation of CPO (including sugars attached to the 
protein). The two channels leading to the active site are marked by arrows, and the heme 
is shown in magenta. The halide binding site 2 (yellow, bromide; blue, iodide) is located 
within the narrow channel and the iodide specific binding site 3 at the end of the channel 
implicating a pathway for halide access from the surface to the heme though this narrow 
channel (Kuhnel 2006). 
 
The narrow channel is composed of very bulky and hydrophobic residues near the 
heme center, but is made of small and polar residues far away from the active center. 
Such a structure can facilitate the access and orientation of certain substrates to the heme 
active site. The propionate edge of the heme group is not accessible for substrates, 
although a substrate pocket is close to the heme. Therefore, the structure of CPO active 
Narrow Channel
Wide Channel 
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center allows substrates to interact with the heme iron in a unique location for 
stereoselective catalysis (Kuhnel 2006). 
1.6 CPO-catalyzed reactions 
Of all heme peroxidase known to date, CPO is believed to be the most versatile 
enzyme on the basis of many types of reactions it catalyzes. The first type of reaction is 
halogenation in which hydrogen peroxide or other hydroperoxides is used as the initiator, 
halides (except fluoride) and compound susceptible to halogenation reactions serve as the 
substrates (Fig 1.6) (Hallenberg 1978). The second category is very similar to the first 
one, except that the substrate is the uric acid. These two reactions may form a similar 
chlorinated intermediate in the initial step, therefore they have optimum acidic pH values 
(Hallenberg 1978; Shahangian 1981; Libby 1982). The third one is a typical peroxidation 
reaction with the pH optimum between4 and 7 depending on the nature of organic 
substrates involved.(Sun 1994). Chloroperoxidase can also catalyze the 
disproportionation of hydrogen peroxidase, a reaction specific to catalases.. Recent 
studies show that CPO is able to catalyze P450-like monooxygenase reactions (Fig 1.7) 
(Sundaramoorthy 1995). Finally, CPO has been shown to catalyze the dehalogenation of 
selected halogenated aromatic compounds (Dawson 1976). 
In recent years, CPO has attracted significant interests for its great industrial 
potential to synthesize enantioselective products. It has been reported that CPO can 
catalyze chiral epoxidation, sulfoxidation, and hydroxylation with good yield (Allain 
1993; Dexter 1995; Zaks 1995).  
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Fig 1.6 Halogenations catalyzed by chloroperoxidase. The substrates are:1 alkenes; 2 β-
diketones such as monochlorodimedone (MCD); 3 alkynes; 4 anisole; 5 phenol; 6 non-
phenolic lignin model compound. X stands for halide. 
16 
 
 
 
Fig 1.7 Oxidations catalyzed by by chloroperoxidase. The substrates are: 1 chloroaniline; 
2 N-dealkylation, e.g., demethylation of N,N-dimethylaniline; 3 thioanisole; 4 1,2-
dihydronaphthalene; 5 indole; 6 propargylic hydroxylation; 7 p-methylanisole; 8 pxylene. 
These reactions are initiated by hydrogen peroxide. 
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The advantage of CPO catalyzed chiral reactions is that there is no need to supply 
NAD(P)H or other electron donor as in cytochrome P450 catalyzed reactions.These 
properties give CPO a bright future in industrial applications, especially in chiral drug 
synthesis, oil purification and agrochemical production (Dexter 1995; Miller 1995; Hager 
1998). 
1.7 Mechanism of CPO-catalyzed reactions 
The unique active site structure makes CPO adept in catalyzing a variety of reactions 
and become a promising candidate for industrial applications. The general mechanism of 
CPO catalyzed reactions is summarized in Fig 1.8. The resting state of the enzyme 
contains a ferricheme center. Binding of hydrogen peroxide at the heme iron initiates the 
reaction. Two electrons are then transferred from the heme center to hydrogen peroxidase, 
resulting in the heterolytic cleavageof the peroxide bond and the formation of a water 
molecule and activated heme intermediate compound I.  
It has been reported that compound I is a common intermediate involved in most 
heme peroxidase catalyzed reactions. The chemical structure of compound I has been 
experimentally determined to be an oxo-ferryl porphyrin cation-radical [heme (Fe4+=O)·+]. 
Depending on the nature of proteins, compound I of heme proteins can participate in 
dramatically different chemical reactions. In the catalase reactions, compound I will 
interact with the second molecule of hydrogen peroxide, to form dioxygen and reduce 
heme iron to the ferric resting state. In peroxidation reactions, compound I can convert 
organic molecules (HA) to radical products (A·) and be reduced to compound II by 
transferring one electron to the organic substrate (Hager 1972; Palcic 1980; Nakajima 
1985). The structure of compound II is assumed to be in the form of FeIV=O. Oxidation  
18 
 
 
 
 
Fig 1.8 Mechanism of CPO-catalyzed reactions. AH represents the substrate and the oval 
represents the heme plane. Compounds I and II represent the ferryl intermediates; X 
represents halides involved in the halogenation pathway.  
 
of a second substrate can also regenerate the ferric resting state for the following cycles 
of the reactions. However, in the chlorination reactions, compound I can interact with 
chloride ion to form a ferric complex named compound X (heme Fe3+–O–X), which is 
unstable and can easily decompose to result in the resting state of the enzyme, halonium 
ion (X+) and hydroxyl ion (OH−). They can further react to form the hypohalous acid 
19 
 
(HOX). The mechanism for the chlorination of hydrocarbons by CPO is still a puzzle, as 
well as the detailed structure of compound X formed in the chlorination reaction (Stefano 
Colonna 2000; Hofrichter 2006). 
1.8 Heterologous expression of CPO 
Controlled heterologous expression of target genes has become a very useful 
technique in biochemistry and molecular biology. For characterization of CPO, an 
efficient heterologous expression system is necessary for site-directed mutagenesis 
because CPO has many post-translational modifications during protein synthesis, e.g., 
glycosylation, disulfide bond formation, and prosthetic group incorporation. Therefore, 
prokaryotic hosts, such as Escherichia coli expression systems, are not applicable for 
synthesis of the active form of chloroperoxidase (Frandsen 1994; Visser 1995; Inoue 
1996; Sriprang 2006). It was reported that a non-glycosylated apoprotein had been 
expressed in an E. coli (Zong 1995; Conesa 2001). Therefore, eukaryotic expression 
systems are the ones suitable for expression of CPO mutants. The baculovirus expression 
system was also studied to explore the possibility of synthesizing CPO with post-
translational modifications. However, inactive enzyme was isolated that could not be 
converted to functional protein (Conesa 2001). The Saccharomyces cerevisiae and Pichia 
pastoris systems both failed to express active CPO mutant (Zong 1997; Sigle 1993). 
Another strategy for CPO expression was to express the protein in the parental host 
Caldariomyces fumago. However, the presence of wild-type CPO in the background 
hampered this because of the impossibility of separating the native enzyme from the 
specific recombinant protein (Zong 1995; Yi 1999). 
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1989). However, the yield of the active recombinant enzymes is still far from expectation 
(Conesa 2001), which makes the reconstruction and culturing of metalloproteins still a 
challenging research subject. 
1.9 Expression of deuterated CPO 
In recent years, deuteration techniques have become a powerful method in studying 
proteins or other biological systems using NMR spectroscopy (Savenkova 2001). 
Deuteration of the solvent or the culturing medium provides the chance to simplify the 
proton NMR spectrum and to suppress the signals of background noise, such as water 
protons. The estimated deuteration level can be evaluated and optimized for high-
resolution proton NMR study. 
It has been reported that deuterium-labeled proteins can be overexpressed in bacteria 
culturing media containing D2O and either protonated or deuterated carbon sources, 
depending on the aim of different deuterium incorporations (Gardner and Kay, 1998). 
Although many bacteria and eukaryotic cells can tolerate culturing media containing a 
certain concentration of D2O, the reduction of cell growth rates and lower protein yields 
are still widely observed in deuterated culturing media (Katz and Crespi, 1970). The 
reason for the depressing effects of deuterium on expression systems is probably that the 
deuterated solvent can cause severe isotope effects and replacement of hydrogen by 
deuterium can damage C-H bond formation. It is widely known that the deuterium 
isotope effects can decrease the rates of enzyme-catalyzed reactions, influence ionic 
equilibrium, weaken the strength of hydrogen bonds, and damage the stability of protein 
structures (Saur et al., 1968a, b; Katz and Crespi, 1970; Schowen, 1977; Schowen and 
Schowen, 1982). 
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In 2001, cytochrome c peroxidase was overexpressed in E. coli using 97-99.9% 
deuterated medium with excess histidine at natural proton isotope abundance (Savenkova 
2001). The results showed that histidine was incorporated into the deuterated 
recombinant enzyme without degradation. Therefore, this technique can be applied to 
obtain the complete set of heme proton assignments as well as the assignments of certain 
amino acids close to the active site. However, the fungi expression systems have never 
been tested in deuterated medium.  
  
23 
 
CHAPTER II 
ENGINEERING THE NARROW SUBSTRATE CHANNEL IN CPO 
2.1 Background 
2.1.1 Location of asparagine 74 
The most important function of CPO is to bind halides and catalyze chlorination, 
bromination and iodination reactions (Thomas 1970; Sono 1986). The crystal structure of 
CPO bound to bromide/iodide instead of chloride has been published as a result of the K-
edge of chloride at 4.39 Å (Kuhnel 2006). The bromide/iodide binding site (I/Br1) is 
located on the surface of CPO, and is occupied 60% by bromide and 30% by iodide in the 
crystal structure (Fig 2.1). The function of this site is probably to serve as the docking 
position for halide anions, to stabilize the hydrogen bond with the backbone amino acids 
and to participate in the interaction with water molecules. The second binding site (I/Br2) 
located within the narrow channel is 8 Å away from I/Br1 binding position. The second 
site has a low occupancy with 20% of iodide and 30% of bromide because it is also 
involved in a hydrogen bonding network with water molecules instead of interacting with 
bound anions. The third binding site is specific for iodide (I3) with an occupancy of 40% 
iodide. The I3 binding site is located 6 Å away from halide binding site 2 and 8.8 Å away 
from the heme iron at the end of the narrow channel. The iodide specific binding site I3 
can form hydrogen bonds with the amide group of Asn 74 and water molecules in the 
middle of the wide channel (Fig 2.2). However, the surrounding environment of I3 is 
hydrophobic and close to the amino acids leucine 70, phenylalanine 103, isoleucine 179, 
and alanine 267. The three halide binding sites mentioned above indicate that the narrow 
channel is the pathway for halides to enter the heme active center. The other four halide 
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binding sites with different halide occupations are positioned on the surface of the 
enzyme where anions replace water molecules from the solvent. The halide anions are 
involved in the formation of hydrogen bonds with side chains of the protein backbone 
and the ion pairs with positively charged basic residues. Although the surface binding 
sites can also interact with some symmetry-related amino acids, they are too far away 
from the narrow channel to be relevant to the enzyme catalysis. The ends of the narrow 
channel and the wide channel are mainly composed of hydrophobic amino acids except 
glumatic acid 183 and asparagine 74. Below the two channels, Phe 186 and Phe 103 are 
6.2 Å away from the heme iron and are almost parallel to the top of the heme plane to 
shield the active center from the solvent. 
 
Fig 2.1 Binding of halides to chloroperoxidase. The anomalous difference maps are 
calculated from iodide (blue) and bromide data (red). Besides the halide binding sites, the 
heme iron located next to the heme also show anomalous signals. The weaker peaks 
visible in the iodide anomalous difference map are caused by the sulfur atoms of 
methioanine and cystidine. 
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Fig 2.2 Stereoview of the active site with bound iodide. The 1.15-Å electron density map 
is shown for selected residues, including the iodide (magenta). 
 
2.1.2 Function of asparagine 74 
The natural function of CPO is to catalyze the chlorination of cyclopentanedione 
(CPD) during the biosynthesis of caldariomycin. When CPD binds at the heme center, it 
is sandwiched between phenylalanine 103 and phenylalanine 186. The carbonyl oxygen 
of CPD forms hydrogen bonds with two water molecules, one of which in turn forms a 
hydrogen bond with Asn 74 at the iodide specific binding site (Fig 2.3). The iodide 
binding site is also a binding position for other polar compounds, including dimethyl 
sulfoxide (DMSO), acetate and ethylene glycol (Fig 2.4). The function of the iodide 
binding site (I3) may serve as an intermediate site for the substrates to be oriented at the 
heme center. Asparagine 74 can form hydrogen bonds with these polar substrates, which 
makes this position favorable for substrate binding. Therefore, the position and polarity 
of Asn 74 may affect the stereoselectivity of CPO-catalyzed reactions (Kuhnel 2006). 
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Fig 2.3 Structure of CPO complexed with cyclopentanedione. 
 
 
 
Fig 2.4 Structure of CPO complexed with cyanide and dimethyl sulfoxide. 
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2.1.3 Aim of this study 
To verify the effects of Asn 74 on the stereoselectivity of CPO-catalyzed reactions, 
the site can be mutated to an aliphatic residue with a similar size (N74V) or a polar amino 
acid with a bigger size (N74Q). These substitutions are chosen because valine is similar 
in size to asparagine but is much more hydrophobic. On the other hand, glutamine is 
polar but bigger compared with asparagine. Site-directed mutagenesis can be carried out 
to produce these mutants. 
2.2 Material and Methods 
2.2.1 Materials 
Marine fungi Caldariomyces fumago and filamentous fungi Aspergillus niger 
(MGG029) were purchased from American Type Culture Collection (ATCC) (Manassas, 
VA). Gene expression vector pCPO3.I-Amds and co-transformation plasmid pAB4.1 
with a selection marker (GenBank accession no. AJ300448) were kindly provided by Dr. 
Punt (TNO Nutrition and Food Research Institute, Netherlands). Restriction enzymes 
were purchased from New England Biolabs (Beverly, MA). Ultra-Pfu DNA polymerase 
with relatively high fidelity was obtained from Stratagene (San Diego, CA). Purified 
oligonucleotide primers were obtained from MWG-Biotech (Ebersberg, Germany). The 
QuickChange site-directed mutagenesis kit was purchased from Stratagene (La Jolla, CA). 
De-ionized water for all the experiments were prepared freshly by Milli-Q Biocel 
(Millipore, Billerica, MA). The JASCO J-720 spectropolarimeter was used to record far 
UV-CD spectra from 190 to 250 nm. Ultraviolet-Visible absorption was monitored using 
a VARIAN Cary 300 spectrophotometer. 
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the plasmid containing the gene for wild-type chloroperoxidase. The results were 
examined by SDS-PAGE electrophoresis (Fig 2.7).  
 
Fig 2.7 Restriction map of CPO mutant coding region. Lane 1. Low molecular weight 
ladder; lane 2. Wt CPO (digested by BstN I); lane 3. N74Q (digested byBstN I); lane 4. 
Wt CPO (no digestion); lane 5. Wt CPO (digested by HpyCH4 III); lane 6. N74V 
(digested by HpyCH4 III). 
 
2.2.4 Gene transformation of the CPO mutants 
Filamentous fungus MGG029 strain was inoculated in 125 mL of minimal media 
with 10 mM uridine and 0.1 mg/mL carbonicilin and cultured for 7 days at 30 degrees 
Celsius. Mycelia from the fungi were disrupted by using a homogenizer for 20 secs, 
disruption by homogenization was repeated twice and the contents were then transferred 
to 2 L of minimal media. The cultures were incubated for 20 hours at 250 rpm and 30 
degrees Celsius. Mycelia were filtered through the sterile myracloth and resuspended in 
1.7 Osm (0.27 M CaCl2, 0.6 M NaCl) buffer. Protoplasts were then treated with 7.5 
161bp 
 
634 bp 
 
473 bp 
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mg/mL lysing enzyme (Interspex, Sigma L-1412) for 4 hours at 150 rpm and 37 degrees 
Celsius. Digested protoplasts were resuspended and incubated on ice for 20 minutes. 
After centrifugation (3500 rpm, 15 minutes, 0 ºC), samples were washed twice with STC 
1700 (1.2 M sorbitol, 10 mM Tris-HCl at pH 7.5, 50 mM CaCl2, 35 mM NaCl), and the 
protoplasts were resuspended in STC1700 and mixed with 10 μg pCPO3.I-Amds mutant 
plasmid and 1 μg pAB4.1 co-transformation plasmid,  then incubated at 25 ºC for 25 
minutes. In three steps, 60% PEG4000 in 10 mM Tris-HCl at pH 7.5 and 50 mM CaCl2 
were carefully mixed with the treated protoplast mixture and diluted by addition of 5~10 
mL of STC1700 to spread on 1.2 M sorbitol selective agar medium plates (Fig 2.8). 
 
 
Fig 2.8 Single mutants N74V (left) and N74Q (right) grown on 1.2 M sorbitol selective 
agar plates after transformation. 
 
2.2.5 Expression of the N74V/N74Q mutant protein 
Filamentous fungi were cultured in A. niger minimal growth medium containing 50 
g/L maltose, 10 g/L glucose, 5 g/L casamino acid, 6 g/L NaNO3, 0.5 g/L KCl, 0.8 g/L 
KH2PO4, 1 g/L K2HPO4, 0.25 g/L MgSO4, 0.1 mM heme precursor and 100 mg/L 
carbenicillin. After culturing in a rotary shaker at 250 rpm, 25 ºC for 24 hours, the fungi 
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were continued to grow at 22 ºC for an additional 6 days. Chlorination activity of the 
culturing medium was examined daily for the yield of the mutant protein using the MCD 
assay. 
2.2.6 Purification of the mutant protein 
Collection of culturing medium was carried out by filtering through Myracloth and a 
0.8 µm membrane to remove the fungi and mycelium. After that, a high output 
ultrafiltration cell with 30 kDa molecular weight cut off membrane was used to condense 
the large volume of crude medium. About 100 mL samples were collected and dialyzed 
in 4 L buffer containing 25 mM potassium phosphate at pH 5.9 for 24 hours with at least 
one buffer exchange. For protein purification, diethylaminoethyl (DEAE) sepharose fast 
flow column (Amersham, 2.6 × 20 cm) and sephadex G-75 column (Amersham, 2.6 
× 100 cm) were applied. Ion exchange chromatography was used to separate the desired 
protein from others by ionic strength gradient difference (0-0.5 M NaCl) at pH 5.9 in 25 
mM potassium phosphate buffer. All experiments were carried out at 4 ºC to keep the 
mutant protein stable. Reinheitzahl (Rz) value was employed to examine the purity of 
enzymes and fractions of Rz > 1.0 were collected and condensed by using Centriprep-
YM30 (Amicon) for further kinetic studies. 
2.2.7 Protein kinetic activity assay 
The absorption spectra were taken at pH 5.9 and 25 ºC in 25 mM potassium 
phosphate buffer. The cyanide and thiocyanate complexes were obtained by adding 2000-
fold excess of KCN and KSCN at room temperature. The reduced forms of CPO and its 
mutants were formed by adding a 1000-fold excess of sodium dithionite, after which the 
solution were saturated with carbon monoxide (CO) to form the CO complexes. 
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Chlorination capability of CPO was measured by the transformation of 
monochlorodimedone (MCD) to dichlorodimedone (DCD). The reaction system 
contained 20 mM KCl, 0.17 mM MCD, appropriate amounts of the enzyme in 100 mM 
phosphate buffer at pH 2.75 and the reaction was initiated by addition of 30 μl of 0.67% 
stock solution of hydrogen peroxide. The rate of formation of DCD product was 
determined from the decrease in the absorbance at 278 nm during the first 20 seconds. 
Epoxidation reaction was carried out in 100 mM sodium acetate buffer at pH 4.5, 
containing 0.2 mM p-nitrostyrene as the substrate and 2 mM Wt CPO or CPO mutants. 
The decrease in the absorbance at 312 nm as a function of time was monitored for the 
rate of formation of p-nitrostyrene oxide. The reaction was initiated by addition of 30 μl 
of 0.67% stock solution of hydrogen peroxide. 
Catalase activity was measured by the rate of absorbance change of H2O2 in 50mM 
phosphate citrate buffer at pH 5.0. The reaction was initiated by the addition of 2 nM Wt 
CPO or CPO mutants. The initial rate of the reaction was determined by measuring the 
decrease in the absorbance at 240 nm during the first 20 seconds. 
In the peroxidation activity assay, 2, 2’-azino-bis-3-ethy-benzthiazoline-6-sulfonic 
acid (ABTS) was used as the electron donor. The reaction mixture was in 100 mM 
phosphate buffer containing 25 mM citric acid at pH 5.0 and initiated by the addition of 
H2O2. The reaction mixture contained 2 nM CPO or CPO mutants, 2.5 mM H2O2, 1.7 
mM ABTS substrate. The initial rate of the reaction was determined by measuring the 
increase in absorbance at 405 nm for the first 20 seconds. 
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2.2.8 Ligand binding study 
Titration experiments were employed to determine the apparent dissociation constant 
(Kd) in the ligand binding. The reaction mixture contained 5 μM enzyme and appropriate 
concentrations of ligands in 25 mM phosphate buffer. The UV-Visible spectroscopy was 
carried out to record the spectrum at different concentrations and the Kd value was 
calculated by using the following formula: Kd = [L] (1-v)/v, where Kd is the apparent 
dissociation constant, [L] is the free ligand concentration and (1-v)/v is the ratio of free 
enzyme to total enzyme concentration. 
2.3 Resutls 
2.3.1 UV-Visible spectroscopic properties of Wt CPO and the N74V mutant 
One of the important characteristics for heme-containing proteins is that they show a 
Soret peak in UV-Vis spectra, which reveals useful information about the heme active 
center. Upon Asn 74 replacement with valine, at pH 5.9, 25℃, the Soret band shifts to 
the red compared to Wt CPO, and the α, β bands become partially resolved. The spectrum 
indicated that the N74V mutant was a hexacoordinate, low-spin ferric heme protein with 
a Soret maximum at 420 ± 1 nm (Fig 2.9). The spectrum of Wt CPO was different from 
the N74V mutant by showing the Soret peak at 398 ± 1 nanometers. The minor peaks of 
N74V mutants were located at 356, 540 and 560 nm, but those of Wt CPO were at 515, 
545 and 650 nm (Fig 2.10). The results indicated that there might be one water molecule 
bound at the heme center of the N74V mutant, and therefore this binding property 
resulted in a low-spin heme at the catalytic center. The spectroscopic properties of the 
N74V mutant and the wild-type enzyme indicated that the active site of the mutant was 
structurally intact. 
35 
 
Wavelength (nm)
300 400 500 600 700
A
bs
or
ba
nc
e
0.0
.1
.2
.3
.4 Wt CPO
N74V
 
Fig 2.9 Absorption spectra of the purified Wt CPO and the N74V mutant in 25 mM 
potassium phosphate buffer at pH 5.9. 
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Fig 2.10 Detailed UV-Vis spectra of Wt CPO and the N74V mutant in 25 mM potassium 
phosphate buffer at pH 5.9. 
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2.3.2 Characterization of CO binding with the N74V mutant 
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Fig 2.11 UV-Visible spectra of the ferrous-CO complex of the N74V mutant in 25 mM 
potassium phosphate buffer at pH=5.9. 
 
The UV-Vis spectra for the ferrous-CO forms of the N74V mutant were obtained to 
examine the coordination structure of the heme iron. The binding of CO with 
hemoproteins is a typical assay for cytochrome P450 enzymes. As is widely known, CO 
complex of thiolate-ligated systems shows an absorption band at approximately 450 nm. 
However in histidine-ligated systems, the corresponding band is blue-shifted to about 420 
nm. It is worth mentioning that the ferrous complexes of the N74V mutant displayed the 
Soret maxium initially at approximately 412 nm upon reduction by addition of sodium 
dithionite. The result could be an indication of changed electron density on the thiolate 
ligand in the reduced form of the CPO mutant. In Wt CPO, the formation of ferrous-CO 
state completely shifted the Soret peak from 400 nm to 445 nm. Compared with Wt CPO, 
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the major peak of the CO complex of N74V shifted slightly from 446 to 443 nm, 
indicating that the proximal ligand in N74V mutant was a cysteine residue (Fig 2.11). 
2.3.3 CD spectroscopic study of the N74V mutant 
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Fig 2.12 Far-UV CD spectra of Wt CPO and the N74V mutant. 0.5 μM enzyme was 
dissolved in 25 mM potassium phosphate buffer at pH 6.0. The experiments were 
recorded from 200 to 300 nm at room temperature. The path length was 1 cm. 
 
The far-UV CD spectra of proteins demonstrated the composition of the secondary 
structure of polypeptide chains. Therefore, CD spectra were used to convey the 
information of secondary structure induced by mutation of the Asn 74 residue. The N74V 
mutant exhibited a slightly different CD spectrum compared with that of Wt CPO (Fig 
2.12). Although the possibility that activities of mutant enzyme were affected by large 
structural changes was excluded, some conformational changes did exist. The secondary 
structural change of the N74V mutant may be attributed to the non-polar distal 
environment of the heme pocket induced by the valine residue. 
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2.3.4 Optimum pH values for Soret band shift 
 
 
 
Fig 2.13 pH profiles for UV-Vis spectra at 400 and 420 nm in the N74V mutant. 
 
The pH dependence of the UV-Vis spectrum of the N74V mutant suggested that an 
ionizable amino acid had become solvent accessible in the absence of asparagine. Since 
Asn to Val mutation partially broke the H-bonds in the network, it would affect the 
dissociation constant of the bound water molecule. To further elucidate the role of the 
N74 residue in the narrow channel, the pH optimum of the N74V mutant was examined. 
After comparing the position of the Soret band at different pH values, we found that the 
Soret band shifted from 420 nm to 400 nm at pH 3.0 (Fig 2.13). The result indicated that 
the N74V mutation provided enough space for a water molecule to bind at the heme 
center. At low pH, the heme bound water molecule becomes protonated and therefore 
dissociates from the heme active center. 
2.3.5 pH profile for MCD assay 
The chlorination ability of the N74V mutant was measured at various pH values 
ranging from pH 2.0 to pH 7.0 (Fig 2.14). For Wt CPO, the optimum pH for chlorination 
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activity was 2.75. However, the N74V mutant was most active at pH 3.5. The changing 
of the optimum pH is normally related to the polarity of the heme distal pocket, which 
affects the catalysis of substrates at the active center. Therefore, it was concluded that the 
mutation at the N74 residue changed the polarity of its local environment and the effect 
was relayed to the heme environment, although N74 was located at the end of narrow 
channel not immediately adjacent to the heme iron. 
 
 
 
Fig 2.14 pH profiles for chlorination activity in the N74V mutant enzyme and Wt CPO. 
2.3.6 Characterization of the N74V mutant activities 
To evaluate the effect of mutation in the narrow channel on the catalytic property of 
CPO, the activities of the N74V mutant were measured with four different assays. As 
expected, the mutation from Asn to Val decreased chlorination and catalase activity rate 
compared with that of Wt CPO because of the decreasing polarity in the heme center (Fig 
2.15). However, the N74V mutant showed much higher epoxidation activity attributable 
to the increased hydrophobicity induced by the mutation. Most epoxidation substrates are 
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non-polar such as styrene and hydrophobic envrionment enhances their interaction with 
the enzyme. 
 
 
 
 
 
 
Fig 2.15 Relative activity of Wt CPO and the N74V mutant in chlorination, catalase, 
epoxidation and peroxidation assays. 
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Fig 2.16 UV-Visible spectra of the cyanide complexes with the N74V mutant at different 
times in 25 mM potassium cyanide alkaline solution at pH=12.0. 
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Fig 2.17 UV-Visible spectra of the cyanide complexes of the N74V mutant at different 
times in 25 mM potassium cyanide solution at pH=6.0. 
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2.3.7 Equilibrium titration of the N74V mutant with cyanide 
The strong binding ligand cyanide was widely used to evaluate the affinity of the 
CPO mutant for the sixth axial ligand. Cyanide can convert high-spin iron to low-spin. 
Thereby, binding of cyanide to Wt CPO shifts the Soret peak from 400 nm to 439 nm. 
The spectral changes of N74V upon addition of cyanide are shown in Fig 2.16. 
As mentioned above, the heme iron in ferric N74V mutant exhibited a low spin form 
without cyanide binding. When KCN bind to the heme iron in basic environment, the 
Soret peak of the complex was first shifted from 420 to 436 nm with a decrease in 
absorbance and then shifted back to 423 nm with increasing absorbance as time passes. 
The spectrum of KCN binding with the N74V mutant was quite different from those of 
Wt CPO, which did not exhibit any blueshift. To evaluate the effect of pH on cyanide 
binding to CPO mutant, the pH of the mixture was adjusted to 6.0. As shown in Fig 2.17, 
the cyanide bound form of CPO N74V mutant displayed a major peak at 436 nm. No 
change in peak position was observed as in the case of basic environment. However, 
remarkable decrease in absorbance at 436 nm was noticed at pH 6.0. In contrary, Wt CPO 
cyanide complex showed the Soret peak at 439 nm without further changes. It is, 
however, difficult to explain the unusual cyanide binding behavior displayed by Asn74 at 
this time. It was reported that lack of polarity in the heme pocket of S. inaequivalvis 
hemoglobin was considered to be a major factor in the cyanide complex stabilization 
(Boffi, Chiancone et al. 1997). These results indicated that the native Asn74 residue was 
critical to the Fe3+-CN binding phenotype.  
The study of the pH dependence upon addition of cyanide conveyed important 
information about cyanide coordinated heme iron state because cyanide could easily bind 
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to the Fe3+ heme in proteins. At pH 6.0, the spectra of N74V mutant cyanide complex 
indicated a typical hexacoordinate, low-spin ferric heme protein with the Soret peak at 
436 nm. However, above pH 10.0, the Soret peak was blue shifted with maxium 
absorption at 423 nm. The reason for the observed spectral shifts is beyond our access 
with our current data available. 
2.3.8 N74V KSCN binding 
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Fig 2.18 UV-Visible spectra of the thiocyanate complexes of the N74V mutant in 25 mM 
potassium phosphate buffer at pH 6.0 with 5 µM enzyme concentration. The ligand 
concentration was from 1 to 20 mM. 
 
 Potassium thiocyanate was also a widely used ligand for studying ligand binding 
properties of heme proteins. The UV-Vis spectra of the SCN complex of CPO N74V 
indicated that there was no Soret peak shift as shown in the cyanide complex (Fig 2.18). 
The maximum absorbance remained to 422 nm with the decreasing absorbance as the 
concentration of thiocyanate increased. 
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2.3.9 N74V halide binding study 
 
Halide pKa Soret peak 
Kdapp (mM) 
pH=2.0 pH=3.0 pH=4.0 
Cl- -2.2 418 801.8 957.1 878 
Br- -4.7 419.5 617.9 788.2 616 
I- -5.2 421 209.1 248.1 204.5 
 
Table 2.1 Apparent Kd for halide binding of the N74V mutant. 
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Fig 2.19 UV-Visible spectra of halide complexes of the N74V mutant in 25 mM 
potassium phosphate buffer at pH 6.0 with 5 µM enzyme concentration. 
 
Chlorination activity was the most prominent feature for CPO (Libby 1982). It has 
been proposed that halide binding is related to CPO’s halogenations activity as there were 
several halide binding sites in the narrow channel (add refecences). The halide binding 
study showed that Kd of iodide was the lowest and that of chloride was the highest. It is 
further noted that halide binding affinity toward CPO was not affected by pH values 
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(Table 2.1). However, the Kd of Br- and Cl- complexes of Wt CPO increased from 20 - 30 
mM at pH 2.0 to 400 - 660 mM at pH 3.5 (Sono 1986). And the high concentrations of 
Br- and Cl- ions altered the spectrum of ferric Wt CPO by shifting the maxium absorbance 
from 399 to 422 nm (Sono 1986). The Soret peak of iodide bound complex was located at 
421 nm, which was 3 nm different with that of the chloride compound. The close 
proximity of Asn74 to iodide binding site Ⅲ accounts for the observed effects after 
mutation of this residue to a more hydrophobic amino acid. 
2.3.10 kcat & KM values in halogenation and epoxidation reactions 
 KM (μM) kcat (S-1) kcat/KM (μM-1 S-1) 
MCD Wt CPO 4.7±1.2 0.24±0.02 5.0×10-2 
N74V 1.1±0.16×102 0.23±0.01 2.0×10-3 
Styrene Wt CPO 1.34±0.12×104 0.63±0.18 4.7×10-5 
N74V 5.5±0.43×102 2.2±0.8 4.0×10-3 
 
Table 2.2 Kinetic parameters of MCD chlorination and styrene epoxidation reactions by 
Wt CPO and the N74V mutant. 
 
Kinetic parameters for the Wt CPO and N74V mutant catalyzed halogenation and 
epoxidation reactions were examined with MCD and styrene as the respective substrates 
(Table 2.2). The N74V mutant has a higher Km value in the halogenation reaction but 
much lower Km in the epoxidation reaction compared to those of wild type 
chloroperoxidase. However, the turnover number of the N74V mutant is similar or higher 
than that of wild type chloroperoxidase. Therefore, the mutation did not or only little 
affected the catalytic efficiency of the enzyme, as proved by the comparable kcat/Km 
values between Wt CPO and CPO N74V. 
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2.4 Results of the N74Q mutant 
2.4.1 UV-Visible spectroscopic properties of Wt CPO and the N74Q mutant 
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Fig 2.20 Absorption spectra of the purified Wt CPO and the N74Q mutant in 25 mM 
potassium phosphate buffer at pH 5.9. 
 
Similar to the UV-Vis spectra of N74V enzyme, the N74Q mutant showed the 
characteristics of Soret maxinum at around 420 nm (Fig 2.20). The minor peaks were 
located at 355, 541 and 560 nm (Fig 2.21). The peak at 355 nm serves as an indicator for 
the low spin heme at the reactive center. The spectral difference exhibited by N74Q 
mutant compared with that of Wt CPO was possibly due to the binding of a water 
molecule to the heme iron.  
2.4.2 CD spectroscopic study of the N74Q mutant 
To demonstrate the secondary structure of chloroperoxidase mutants, a far-UV CD 
spectrum of the N74Q mutant was obtained (Fig 2.22). The result showed that there was 
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no apparent difference in the spectra induced by the site directed mutagenesis. Even some 
conformational changes exist, they must have been very localizedand undetectable. 
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Fig 2.21 Detailed UV-Vis spectra of Wt CPO and the N74Q mutant in 25 mM potassium 
phosphate buffer at pH 5.9. 
 
2.4.3 Characterization of CO binding to the N74Q mutant 
Ultraviolet-visible spectroscopy was carried out to examine the binding of the N74Q 
mutant with carbon monoxide (CO). The CO complexes of thiolate-ligated heme 
peroxidases give an absorption band at 450 nanometers. However, in the histidine-ligated 
systems, that band is blue-shifted to 420 nanometers. As mentioned before, in Wt CPO, 
the formation of the ferrous-CO state completely shifted the Soret peak from 400 nm to 
445 nm (Fig 2.23). After reducing iron in the N74Q mutant from ferric to ferrous, the 
major peak was partially shifted from 420 nm to 443 nm after CO is bound, indicating 
that the proximal ligand in the N74Q mutant is identical to that in the Wt CPO. 
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Fig 2.22 Far-UV CD spectra of Wt CPO and the N74Q mutant. 0.5 μM enzyme was 
dissolved in 25 mM potassium phosphate buffer at pH 6.0. The data were recorded from 
200 to 300 nm at room temperature. The path length was 1 cm. 
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Fig 2.23 UV-Visible spectra of the ferrous-CO complex of the N74Q mutant in 25 mM 
potassium phosphate buffer at pH=5.9. 
 
2.4.4 Equilibrium titration of N74Q with cyanide 
Cyanide can convert the high-spin iron state to the low-spin form (Lambeir 1983). 
Therefore, this strong binding ligand was used to evaluate the affinity of CPO for 
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exogenous ligand. In wild type CPO, the Soret peak was shifted from 400 to 439 nm. 
However, the Soret peak of N74V mutant appeared at 423 nm with the decreasing 
absorbance as the concentration of KCN was increased (Fig 2.24). Therefore, the 
mutation from Asn to Gln changed the binding affinity of cyanide at the heme active 
center.  
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Fig 2.24 UV-Visible spectra of the cyanide complexes of the N74Q mutant with different 
substrate concentrations in 25 mM potassium cyanide solution at pH= 6.0. 
 
2.4.5 MCD, ABTS and catalase assays performed with the N74Q mutant 
Chlorination of monochlorodimedone (MCD) to dichlorodimedone (DCD) was used 
to measure the chlorination activity of the N74Q mutant (Fig 2.25). Results showed that 
the N74Q mutant lost almost all its chlorination ability compared to wild-type 
chloroperoxidase. Also, the N74Q mutant lost its catalase activity as a result of mutation  
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Fig 2.25 UV-Visible kinetic spectra of the N74Q mutant MCD assay in 100 mM 
phosphate buffer at pH 2.75. The reaction was initiated by the addition of hydrogen 
peroxide. The decreasing rate of absorbance at 278 nm was recorded. 
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Fig 2.26 UV-Visible kinetic spectra of the N74Q mutant ABTS assay in 100 mM 
phosphate-citrate buffer at pH 5.0. The reaction was initiated by the addition of hydrogen 
peroxide. The increasing rate of absorbance at 405 nm was recorded. 
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Fig 2.27 UV-Visible kinetic spectra of the N74Q mutant catalase assay in 50mM 
phosphate citrate buffer at pH 5.0. The reaction was initiated by the addition of the 
enzyme and monitored at 240 nm. 
 
of the Asn 74 residue. However, in the ABTS assay, the N74Q mutant showed enhanced 
peroxidation ability compared with that of the wild-typre chloroperoxidase (Fig 2.26). 
These results may be caused by the difference of polarity in the distal heme pocket and 
the mechanisms of enzyme-catalyzed reactions. 
2.5 Discussion 
To verify the function of asparagine74, site-directed mutagenesis was used to replace 
Asn74 by either a valine or a glutamine. These substitutions were chosen because Val 
was similar in size tobut dramatically different in hydrophobicity from that of Asn, while 
Gln has a bigger size than Asn but comparable polarity with Asn. The characteristics of 
these mutants were quite different with those of Wt CPO.  
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The spectrum indicated that the N74V mutant was a hexacoordinate, low-spin ferric 
heme protein with a Soret maximum at 420 nm. The minor peaks of the N74V mutant 
were located at 356, 540 and 560 nm. After the heme iron of the N74V mutant was 
reduced from ferric to ferrous and bound to carbon monoxide, the major peak was 
partially shifted from 420 nm to 443 nm, which indicated that the proximal ligand in the 
N74V mutant was a cysteine residue. As expected, mutation from Asn to Val decreased 
the chlorination and catalase reactivity of the N74V mutant, but increased the epoxidation 
ability compared to wild-type chloroperoxidase. Catalase activity was the primary reason 
for the destruction of Wt CPO because of the generated reactive oxygen. In addition, 
epoxidation activity of the Asn74 mutant increased 4-fold compared with that ofwild type 
chloroperoxidase. The results of activity assays could be explained by a non-polar 
environment of the distal heme pocket in the N74V mutant introduced by a Val residue.  
Another important improvement induced by site-directed mutagenesis was the ability 
of the N74V mutant to catalyze the epoxidation of styrene and its derivatives with high 
enantioselectivity that were poor substrates for wild-type chloroperoxidase. Styrene and 
its derivatives are an important group of substrates with significate industrial applications 
(Hager, Lakner et al. 1998). The improvement in kinetic perfection introduced by the 
N74V mutation was reflected by the favorable changes in kcat and kcat/KM values of these 
reactions. Therefore, Asn74 mutant is a promising candidate for industrial applications 
due to its relaxed substrate specificity. 
Interestingly, the N74Q mutant showed similar properties compared to the N74V 
mutant in the halogenation, peroxidation, and catalatic reactions. Since there were no 
significant structural changes in the N74Q mutant as indicated by the CD spectroscopic 
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study, my research on the N74Q mutant could help better understand the mechanisms of 
CPO-catalyzed enantioselective reactions and fine-tune the catalytic properties of 
chloroperoxidase. 
The Asn74 residue may also play a critical role in orienting ligands in the narrow 
channel as reflected in the halide binding behavior. Cyanide binding to the Asn74 mutant 
was investigated as a function of pH using spectroscopic, equilibrium, and kinetic 
methods. The Asn74 mutant has a higher KM value in the halogenation reaction, much 
lower KM in the epoxidation reaction than those of Wt CPO and similar or higher 
turnover numbers compared to those of wild type chloroperoxidase. 
 It is very interesting that a single mutation outside the catalytic center could result in 
such significant changes in the catalytic profile. Although Asn74 was originally proposed 
to form hydrogen bonds with many polar substrates to orient them to the heme catalytic 
center, it could also interact with some nonpolar substrates in the epoxidation of styrene 
and its derivatives. 
The N74 mutants are very interesting targets to study thiolate-ligated hemoproteins, 
as they provide greater enzymatic activities and several clues on how CPO orients its 
substrates to the catalytic center. Since they have a greater resemblance to P450cam in its 
UV-Vis spectrum, the N74 mutants are also better models for understanding the long 
standing and difficult question of P450 mechanism than chloroperoxidase. Therefore, my 
study provides the fundamental principle for understanding the structural and functional 
role of the substrate access channel in thiolate-ligated hemoproteins. It demonstrates the 
feasibility of engineering novel enzymes with tailor-made activities that are effective in 
biocatalysis, bioremediation and other biotechnological applications.  
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CHAPTER III 
CHIRAL STUDY OF CPO MUTANTS 
3.1 Background 
3.1.1 High performance liquid chromatography (HPLC) 
High performance liquid chromatography (HPLC) was first invented in the late 
1960s by using high pressure to detect and separate different compounds (Horváth 1967). 
With the expansion in the use of computers and detectors, HPLC quickly became an 
indispensable technique for the separation of chemical or chiral compounds in different 
industrial fields in the 1980s (Hung 1988). Recently, various types of columns have been 
developed on the basis of different principles of interactions between the samples and the 
stationary phase to separate certain types of compounds, such as ion-exchange, 
adsorption, and chiral columns. In the biochemistry and analytical chemistry field, HPLC 
was also a widely used technique to separate different components in a mixture (Snyder 
2009).  
Two types of phases are used in the liquid chromatographic technique: one is the 
stationary phase and the other is the mobile phase. The stationary phase is positioned in a 
certain type of columns and the mobile phase is driven by a high pressure pump with an 
injected sample to flow through the column to separate the chiral products. The separated 
components are then monitored by a detection unit when they are eluted from the column 
(Fig 3.1). Nowadays, ultraviolet, mass-spectrometry, fluorescence, electrochemical, 
refractive index, and conductivity based detectors are the commercially available 
measuring devices. Among them, the ultraviolet (UV) detector is the most widely used 
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one because of the adequate response to most analyzed chemicals. The operating 
wavelength for the UV detector is from 190 to 700 nanometers.  
 
 
Fig 3.1 Diagram of the chromatographic process in an HPLC unit. 
 
Chiral separation of the enantiomers is quite important in the chiral synthesis, 
biochemistry, pharmacology and medicine field, because the pharmacological and 
toxicological behaviors of the enantiomers can be significantly different (Schmid 2001). 
Efficient and accurate separation of enantiomers is one problem in the development of 
enantioselective drugs with chiral centers (Eichelbaum 2007). In recent years, HPLC has 
been rapidly developed in the chiral application field, which can provide rapid, sensitive 
and efficient sample anaylsis and separation. 
3.1.2 Whelk-O 1 chiral stationary phase 
The versatile and robust Whelk-O 1 column is chosen as the chiral stationary phase 
(CSP) to separate the enantiomers of reaction mixtures because of the nonpolar properties 
of products (Zhao 2009). The chiral stationary phase of the column (Fig 3.2), is a typical 
brush-type compound using 1-(3, 5-dinitrobenzamido)-1, 2, 3, 4- tetrahydrophenanthrene 
 as
te
se
th
in
ef
an
ex
d
F
b
F
 
 
 
 the binding
ther and a s
parate the e
ree direct i
teraction si
fienciency o
d inclusion
traordinary
initrobenzam
urthermore, 
onding netw
 
ig 3.2 Chem
 material. I
iloxane bond
nantiomers 
nteractions 
tes, at leas
f chiral sep
 complexati
 degree of 
ide π-syst
the hydroge
ork. 
ical structur
t is reported
 (Mikes 19
could be co
between the
t one is st
aration. Typ
on are invol
the π-elec
em because
n donor of 
e of Whelk-
56 
 that CSP c
76). The bas
ncluded as 
 enantiomer
ereoselectiv
ically hydr
ved in the in
tron accept
 of the tw
the amide g
O 1. 
an be linke
ic principle
a “three poi
s and the c
ely depend
ogen bondin
teractions. I
or signal i
o electron
roup is oft
d to silica v
 of the Whe
nt rules”, w
hiral select
ent and co
g, π-π or di
n the Whelk
s observed 
-withdrawin
en involved
 
ia a hydroca
lk-O 1 colum
hich summa
or. Among 
ntributed to
pole interac
-O 1 colum
from the 
g nitro gr
 in the hydr
 
rbon 
n to 
rizes 
these 
 the 
tions 
n, an 
3, 5-
oups. 
ogen 
57 
 
Table 3.1 Structures of styrene oxide and its derivatives. 
Substrate Epoxidation products 
 (R)-isomer (S)-isomer 
Ph
 
 
Styrene 
 
Ph
o  
Ph
o  
Ph
 
Cis-β-methylstyrenea 
 
Ph
o  
Ph
o  
Ph
 
Trans-β-methylstyreneb 
 
Ph
o  
Ph
o  
Ph
 
Trans-β-ethylstyrenec 
 
  
Ph
o  
  
Ph
o  
Ph
 
 
Trans-β-ethylstyrened 
Ph
o
 
Ph
o
 
a (1R, 2S)-cis-β-methylstyrene and (1S, 2R)-cis-β-methylstyrene.  
b (1R, 2R)-trans-β-methylstyrene and (1S, 2S)-trans-β-methylstyrene.  
c (1R, 2R)- trans-β-ethylstyrene and (1S, 2S)-trans-β-ethylstyrene. 
d (1R, 2R)- trans-β-propylstyrene and (1S, 2S)-trans-β-propylstyrene. 
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The Whelk-O 1 column is more widely applied than other chiral stationary phases on 
the basis of the covalent bonding to support materials and the tolerance of CSP to many 
organic solvents. In my research, epoxidation products of styrene and its derivatives were 
successfully separated with this column. The (R)- and (S)-styrene oxide and their 
derivatives from tepoxidation reactions catalyzed by Wt CPO and the CPO mutants were 
summarized in Table 3.1. 
3.1.3 Function of histidine 105 
In the distal pocket of CPO, even though the environment around the heme is polar 
like other peroxidases, a glutamic acid instead of a histidine is employed to cleave the 
peroxide bond during the formation of compound I (Yi, Conesa et al. 2003). In the distal 
heme pocket of CPO, glutamic acid 183 is the residue closest to the heme iron and 
involved in CPO reactions as a catalytic acid-base. Histidine 105 is about 3.5 Å away 
from the heme propionate and responsible for formation of a hydrogen bond with Glu183 
(Sundaramoorthy, Terner et al. 1995; Yi, Conesa et al. 2003). When the substrates bind at 
the heme center, the side chain of Glu183 is locked because it forms hydrogen bond to a 
water molecule and a histidine residue. Therefore, Glu183, His105 and Asp106 interact 
together as a proton relay shuttle to facilitate the cleavage of hydrogen peroxidase (Wang 
2003). Acturally the X-ray result of native chloroperoxidase discovered a proton shuttle 
among Glu183, His105, and Asp106 (Sundaramoorthy 1995), which confirmed the 
hypothesis mentioned above.  
Even though His105 is not directly involved in the reaction of chloroperoxidase, it 
may play an important role in the orientation of the glutamine 183 residue. During the 
catalysis, His105 forms a hydrogen bond network between Glu183 and a water molecule 
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or hydrogen peroxide (Wang, Tachikawa et al. 2003). Hydrogen bond network could 
facilitate the cleavage of peroxide oxygen-oxygen bond. Therefore, the replacement of 
histidine to a nonpolar alanine may destabilize/desrrupt the hydrogen bond network, 
giving more freedom for Glu183, and thus lower CPO’s catalytic activities. The change 
of binding properties may increase the enantioselectivity of certain reactions catalyzed by 
CPO mutants. 
3.1.4 Aim of the study 
Histidine 105 (H105) was replaced by a nonpolar amino acid alanine using site-
directed mutagenesis to study the chlorination and catalase activity of the H105A mutant 
because of decreased polarity in the distal heme environment and breakage of the 
hydrogen bond with glutamic acid 183 (E183). Also, enantioselective studies of the 
epoxidation of bulky styrene derivatives can obtain strong evidence for the proposed 
histidine/cysteine ligand switch in chloroperoxidase, providing experimental support for 
the structure of the 420-nm absorption maximum in a number of carbon monoxide 
complexes of heme-thiolate proteins. 
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Fig 3.3 Active site structure of chloroperoxidase. Proximal and distal ligand residues are 
indicated in bold. Heme coordination to the proximal ligand is indicated by a grey solid 
line. Hydrogen bonds are represented by dashed lines (PDB: 1CPO). 
  
Fig 3.4 Proposed mechanism that His 105 facilitates the cl
61 
eavage of the peroxide O–O bond. 
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3.2 Materials and Methods 
3.2.1 Materials 
Marine fungi Caldariomyces fumago and filamentous fungi Aspergillus niger 
(MGG029) were purchased from American Type Culture Collection (ATCC) (Manassas, 
VA). Gene expression vector pCPO3.I-Amds and co-transformation plasmid pAB4.1 
with a selection marker (GenBank accession no. AJ300448) were kindly provided by Dr. 
Punt (TNO Nutrition and Food Research Institute, Netherlands). Restriction enzymes 
were purchased from New England Biolabs (Beverly, MA). Ultra-Pfu DNA polymerase 
with relatively high fidelity was obtained from Stratagene (San Diego, CA). Purified 
oligonucleotide primers were obtained from MWG-Biotech (Ebersberg, Germany). The 
QuickChange site-directed mutagenesis kit was purchased from Stratagene (La Jolla, CA). 
De-ionized water for all the experiments were prepared freshly by Milli-Q Biocel 
(Millipore, Billerica, MA). The JASCO J-720 spectropolarimeter was used to record far 
UV-CD spectra from 190 to 250 nm. Ultraviolet-Visible absorption was monitored by 
using a VARIAN Cary 300 spectrophotometer. 
Styrene, α-methylstyrene, trans-β-methylstyrene, trans-β-ethylstyrene, trans-β-
propylstyrene were purchased from Sigma-Aldrich (St. Louis, MO). A Waters 1525 
instrument equipped with a photodiode array UV-detector (Waters, Milford, MA) was 
used to carry out all HPLC experiments. All instrumental parameters and data analysis 
were set up by using Waters Empower 2 software (Waters, Milford, MA). WhelkO-1 
column (250 mm x 4.6 mm, Regis Technologies, Morton Grove, IL) was used to separate 
the enantiomers in the reaction mixture.  
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3.2.2 H105A mutant gene construction 
Protocols of H105A site-directed mutagenesis were from Stratagene Quikchange Kit 
and PCR amplification. Expression vector pCPO3.I-AmdS with the complete set of cpo 
gene encoded was used as the template. The plasmid was designed to use the A. niger 
glucoamylase as the promoter and A. nidulans trpC as the terminator. A selection marker 
AmdS gene was inserted into the NotI restriction enzyme digestion site.  
Encoded primers for the H105A mutant were 5' ccc cac gct ttc gag GCC gac cac tcc 
ttc tcc 3’. The PCR reactions were carried out by using the following steps: initial 
denaturation at 94 ºC for 1 min followed by 34 cycles at 94 ºC for 30 secs (denaturation) 
and 68 ºC for 6–9 mins (annealing and extension). The desired mutation was confirmed 
by DNA sequencing and the expression vector pCPO3.I-AmdS containing the H105A 
mutation was named as pCPO-H105A-AmdS. The high fidelity Ultra-pfu DNA 
polymerase was employed in the reactions. 
3.2.3 Mutant DNA sequencing and restriction endonuclease digestion 
Results of the H105A single mutation were identified by DNA sequencing and 
construction of a restriction enzyme digestion map. The mutant DNA was extracted from 
the transformed E. coli strain under the instruction of QIAGEN DNA extraction mini kit 
(QIAGEN, CA). The plasmid DNA of the H105A mutant was further examined by 
BsiHKAI restriction endonuclease. The restriction endonuclease cleaved the mutant cpo 
gene at the specific location shown below, which did not exist in the original plasmid 
containing the gene for wild-type chloroperoxidase. The results were examined by SDS-
PAGE gel electrophoresis. The primers (5'-cgc gga tcc atg ttc tcc aag gtc c -3' & 5'- ccg 
gaa ttc aag gtt gcg ggc-3’) were used to amplify the CPO coding region. 
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3.2.4 Mutant gene transformation into A. niger 
Filamentous fungi MGG029/ATCC62590 strain were inoculated in 125 mL of 
minimal media with 10 mM uridine and 0.1 mg/mL carbonicilin, and cultured for several 
days at 30 degrees Celsius. Mycelia from the fungi were disrupted by using a 
homogenizer at the full speed for 20 secs for 3 times and then transferred to 2 L of 
minimal medium. The cultures were incubated for 20 hours at 250 rpm and 30 degrees 
Celsius. Mycelia were filtered through a sterile myracloth and resuspended in 1.7 Osm 
(0.27 M CaCl2, 0.6 M NaCl). Protoplasts were then treated with 7.5 mg/mL lysing 
enzyme (Interspex, Sigma L-1412) for 4 hours at 150 rpm and 37 degrees Celsius. 
Digested protoplasts were resuspended and incubated on ice for 20 minutes. After 
centrifugation (3500 rpm, 15 minutes, 0 ºC), samples were washed twice with STC 1700 
(1.2 M sorbitol, 10 mM Tris-HCl at pH 7.5, 50 mM CaCl2, 35 mM NaCl), and the 
protoplasts were resuspended in STC1700 and mixed with 10 μg pCPO3.I-Amds mutant 
plasmid and 1 μg pAB4.1 co-transformation plasmid and then incubated at 25 ºC for 25 
minutes. In three steps, 60% PEG4000 in 10 mM Tris-HCl at pH 7.5 and 50 mM CaCl2 
were carefully mixed with the treated protoplast mixture and diluted by addition of 5~10 
mL of STC1700 to spread on 1.2 M sorbitol selective agar medium plates.  
3.2.5 Expression of the H105A mutant protein 
Filamentous fungi were cultured in A. niger minimal growth medium containing 50 
g/L maltose, 10 g/L glucose, 5 g/L casamino acid, 6 g/L NaNO3, 0.5 g/L KCl, 0.8 g/L 
KH2PO4, 1 g/L K2HPO4, 0.25 g/L MgSO4, 0.1 mM heme precursor and 100 mg/L 
carbenicillin. After culturing in a rotary shaker at 250 rpm and 25 ºC for 24 hours, the 
fungi continued to grow at 22 ºC for an additional 6 days. Chlorination activity of the 
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culturing medium was examined daily for the yield of mutant protein using the MCD 
assay. 
 
 
Fig 3.5 Single mutant H105A transformed into MGG029 (left) and ATCC62590 (right), 
grown on 1.2 M sorbitol selective agar plates. 
 
3.2.6 Purification of the mutant protein 
Collection of culturing medium was carried out by filtering through the miracloth 
and 0.8 µm membrane to remove the fungi and mycelium. After that, a high output 
ultrafiltration cell with 30 kDa cut off membrane was used to condense the large volume 
of crude medium. About 100 mL samples were collected and dialyzed in 4 L buffer 
containing 25 mM potassium phosphate at pH 5.9 for 24 hrs with at least one buffer 
exchange. For protein purification, DEAE sepharose fast flow column (Amersham, 2.6 × 
20 cm) and Sephadex G-75 column (Amersham, 2.6 × 100 cm) were applied. Ion 
exchange chromatography was used to separate the desired protein from others by ionic 
strength gradient difference (0-0.5 M NaCl) in 25 mM potassium phosphate buffer at pH 
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5.9. All the experiments were carried out at 4 ºC to keep the mutant protein stable. 
Reinheitzahl (Rz) value was employed to examine the purity of enzymes and practions of 
Rz > 0.8 were collected and condensed by using Centriprep-YM30 (Amincon) for further 
kinetic study. 
3.2.7 Protein kinetic activity assay 
Chlorination capability of CPO was measured by the transformation of 
monochlorodimedone (MCD) to dichlorodimedone (DCD). The reaction system 
contained 20 mM KCl, 0.17 mM MCD, certain amounts of the enzyme in 100 mM 
phosphate buffer at pH 2.75 and the reaction was initiated by the addition of hydrogen 
peroxide. The decreasing rate of absorbance at 278 nm was recorded. 
Epoxidation reaction was carried out in 100 mM sodium acetate buffer at pH 4.5, 
containing 0.2 mM p-nitrostyrene as the substrates and suitable aliquots of enzymes. The 
decrease in absorbance at 312 nm as a function of time was monitored. 
Catalase activity of CPO was measured by the rate of decreasing absorbance of H2O2 
in 50 mM phosphate citrate buffer at pH 5.0. The reaction was initiated by the addition of 
the enzyme and monitored at 240 nanometers. 
In the peroxidation activity assay, 2, 2’-azino-bis-3-ethy-benzthiazoline-6-sulfonic 
acid (ABTS) was used the electron donor. The reaction mixture was in 100 mM 
phosphate-citrate buffer at pH 5.0 and initiated by the addition of hydrogen peroxide. The 
increase of absorbance at 405 nm was recorded. 
3.2.8 Epoxidation of styrene and its derivatives catalyzed by H105A 
Styrene and its derivatives (α-methylstyrene, cis-β-methylstyrene, trans-β-
methylstyrene, trans-β-ethylstyrene, and trans-β-propylstyrene) were used to study the 
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enantioselectivity of Wt CPO, H105A and N74Q mutants in the epoxidation assay. The 
reaction mixture was composed of 100 µl of tert-butyl hydroperoxide and 70 µL of 
styrene or other styrene derivatives. The reaction was triggered by the addition of 25 µL 
reaction mixture into 750 µL 100 mM citrate buffer at pH 5.5. About 2 mg of Wt CPO or 
mutants was added to reaction mixture. After incubated in the shaker at 150 rpm and 
room temperature for 3 hrs, the reaction products were extracted three times using 300 
µL isooctane (Sigma-Aldrich, St. Louis, MO). 
3.2.9 Chiral separation of CPO epoxidation products by HPLC 
A Whelk-O 1 column was used as the stationary phase to separate the chiral products 
of the expoxidation reactions catalyzed by Wt CPO, H105A and N74Q mutants. The 
mobile phase was hexane mixed with 0.2% to 2% ethanol. The flow rate was 1.0 mL/min 
at 4 ºC or room temperature. The injection volume of each sample was set to 20 µL. The 
UV-Visible absorption wavelength for the chiral products was ranged from 208.6 to 
218.6 nm. Retention time and peak intensity were not optiminzed at some cases to get the 
better separation results of the enantiomers. 
3.2.10 Data analysis 
Parameters used to analyze the CPO and its mutants catalyzed epoxidation products 
were shown as follows: 
Retention factor: k’ = (tR – t0)/ t0 
where tR was the retention time and t0 was the void time; 
Separation factor: α = k2’ / k1 ’ 
where k1 ’ and k2’ represented the retention factors of two eluted enantiomers; 
Resolution factor: Rs = 2(tR2 - tR1)/ (W1+W2) 
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where tR1 and tR2 standed for the retention times of two eluted enantiomers and W1 and 
W2 were related individual peak widths. 
ee= % (major isomer) - % (minor isomer ) 
3.3 Results 
3.3.1 UV-Visible spectroscopic properties of Wt CPO and the H105A mutant 
An important characteristic of heme-containing proteins is that they show a Soret 
peak in UV-Vis spectra, which can reveal useful information about the heme active 
center. The spectrum indicated that the H105A mutant was a hexacoordinate, low-spin 
ferric heme protein with a Soret maximum at 418 ± 1 nm (Fig 3.6). The spectrum of Wt 
CPO was different from that of the H105A mutant by showing the Soret peak at 398 ± 1 
nanometers. The minor peaks of the H105A mutant were located at 345, 540 and 580 nm, 
but those of Wt CPO were at 515, 545 and 650 nm, respectively. Results indicated that 
there was one water molecule bound to the heme iron in the H105A mutant, and therefore 
gave a low-spin heme at the catalytic center.  
3.3.2 UV-Vis spectroscopy of Wt CPO, rCPO and H105A with CO at different pH 
The properties of Wt CPO, recombinant CPO (rCPO) and the H105A mutant in their  
ferric or ferrous forms and their carbon monoxide (CO) complexes were examined using 
UV-vis spectroscopy. The CO binding method is a typical assay for cytochrome P450 
enzymes. As is widely known, the CO complexes of thiolate-ligated hemoperoxidases 
show a characteristic absorption band at around 450 nanometers. However in the 
histidine-ligated systems, the Soret band is blue-shifted to 420 nanometers. In Wt CPO, 
the formation of ferrous-CO state completely shifted the Soret peak from 400 nm to 445 
nm at pH 5.9. But at different pH, the patterns of spectra were quit different for Wt CPO, 
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rCPO and the H105A mutant (Fig 3.7-Fig 3.15). By replacement of the distal histidine by 
alanine, the peak of the CO complex at 425 nm did not disappear, which indicated that 
there was partial histidine/cysteine ligand switch in the distal and proximal heme pockets. 
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Fig 3.6 Absorption spectra of the purified Wt CPO and H105A mutant in 25 mM 
potassium phosphate buffer at pH 5.9. 
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Fig 3.7 UV-Visible spectra of the ferric Wt CPO in 25 mM potassium phosphate buffer at 
different pH values of 6.5, 7, 8, 9, 10, and 11. 
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Fig 3.8 UV-Visible spectra of the ferric recombinant CPO in 25 mM potassium 
phosphate buffer at different pH values of 6.5, 7, 8, 9, 10, and 11. 
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Fig 3.9 UV-Visible spectra of the ferric H105A in 25 mM potassium phosphate buffer at 
different pH values of 6.5, 7, 8, 9, 10, and 11. 
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Fig 3.10 UV-Visible spectra of the ferrous Wt CPO in 25 mM potassium phosphate 
buffer at different pH values of 6.5, 7, 8, 9, 10, and 11. 
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Fig 3.11 UV-Visible spectra of the ferrous recombinant CPO in 25 mM potassium 
phosphate buffer at different pH values of 6.5, 7, 8, 9, 10, and 11. 
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Fig 3.12 UV-Visible spectra of the ferrous H105A in 25 mM potassium phosphate buffer 
at different pH values of 6.5, 7, 8, 9, 10, and 11. 
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Fig 3.13 UV-Visible spectra of the ferrous Wt CPO and CO complex in 25 mM 
potassium phosphate buffer at different pH values of 6.5, 7, 8, 9, 10, and 11. 
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Fig 3.14 UV-Visible spectra of the ferrous recombinant CPO and CO complex in 25 mM 
potassium phosphate buffer at different pH values of 6.5, 7, 8, 9, 10, and 11. 
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Fig 3.15 UV-Visible spectra of the ferrous H105A and CO complex in 25 mM potassium 
phosphate buffer at different pH values of 6.5, 7, 8, 9, 10, and 11. 
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3.3.3 Epoxidation of styrene catalyzed by Wt CPO and the H105A mutant 
Products of the styrene epoxidation catalyzed by Wt CPO and the H105A mutant 
were separated and identified by HPLC (Fig 3.16 and 3.17). The resolution factor Rs, 
calculated for Wt CPO, was 1.07 and for the H105A mutant was 1.01. The retention 
factors k1’ and k2’ for Wt CPO were 1.90 and 2.90, and for the H105A mutant they were 
1.97 and 2.95, respectively. The separation factor α for Wt CPO was 1.53 and for H105A 
mutant was 1.50. It was reported that the elution order of the similar enantiomers by the 
Whelk-O 1 column was (R)-enantiomers before (S)-enantiomers. The dominant product 
for Wt CPO was (R)-styrene oxide, which had a shorter retention time than (S)-styrene 
oxide and the enantiomeric excess (ee) value was 43.64%. However, the H105A mutant 
catalyzed reaction yielded only 0.06% of the ee value.  
 
Fig 3.16 Enantioselective separation of styrene oxide formed in catalysis by Wt CPO on 
Whelk-O 1 column at the room temperature using n-hexane/ethanol (99.9/0.1, v/v) as the 
mobile phase. The monitoring wavelength was 215.7 nm. 
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Fig 3.17 Enantioselective separation of styrene oxide formed in catalysis by the H105A 
mutant on Whelk-O 1 column at the room temperature using n-hexane/ethanol (99.9/0.1, 
v/v) as the mobile phase. The monitoring wavelength was 215.7 nm. 
 
3.3.4 Epoxidation of cis-β-methylstyrene catalyzed by Wt CPO and H105A 
The epoxidation products of cis-β-methylstyrene catalyzed by Wt CPO and the 
H105A mutant were separated and studied by HPLC (Fig 3.18 and 3.19). Wt CPO-
catalyzed epoxidation of cis-β-methylstyrene had only one product, which was the (1S, 
2R)-enantiomer. However, the H105A-catalyzed reaction generated the byproduct. The 
resolution factor Rs calculated for the H105A mutant was 0.739. The retention factors k1’ 
and k2’ for the H105A mutant were 6.90 and 7.95, respectively. The separation factor α 
for the H105A mutant was 1.15. The enantiomeric excess (ee) value of the H105A 
mutant was 13.52%, which indicated that this mutation caused partial loss of 
enantioselectivity for cis-β-methylstyrene. 
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Fig 3.18 Enantioselective separation of cis-β-methylstyrene oxide formed in catalysis by 
Wt CPO on Whelk-O 1 column at 4 ºC using pure hexane as the mobile phase. The 
monitoring wavelength was 215.7 nm. 
 
 
Fig 3.19 Enantioselective separation of cis-β-methylstyrene oxide formed in catalysis by 
the H105A mutant on Whelk-O 1 column at 4 ºC using pure hexane as the mobile phase. 
The monitoring wavelength was 215.7 nm. 
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3.3.5 Epoxidation of trans-β-methylstyrene catalyzed by Wt CPO and H105A  
 
The epoxidation products of trans-β-methylstyrene catalyzed by Wt CPO and the 
H105A mutant were separated and identified by HPLC after comparing the retention 
times of the products with the pure standards (Fig 3.20 and 3.21). The elution order of 
epoxidation products for this reaction was that the (1R, 2R)-enantiomer preceded the (1S, 
2S)-enantiomer. The resolution factor Rs calculated for Wt CPO was 3.19 and for the 
H105A mutant was 2.40. The retention factors k1’ and k2’ for Wt CPO were 2.02 and 
4.31, and for the H105A mutant they were 2.02 and 4.36, respectively. The separation 
factor α for Wt CPO was 2.13 and for the H105A mutant was 2.16.  
 
Fig 3.20 Enantioselective separation of trans-β-methylstyrene oxide formed in catalysis 
by Wt CPO on Whelk-O 1 column at the room temperature using n-hexane/ethanol 
(99.9/0.1, v/v) as the mobile phase. The monitoring wavelength was 215.7 nm. 
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The ee value for Wt CPO was 0.08%. However, the H105A mutant catalyzed 
reaction gave 48.04% ee. So the mutation of H105 amino acid allowed the better 
positioning of trans-β-methylstyrene at the heme center and increased the 
enantioselectivity for this substrate. 
 
 
Fig 3.21 Enantioselective separation of trans-β-methylstyrene oxide formed in catalysis 
by the H105A mutant on Whelk-O 1 column at the room temperature using n-
hexane/ethanol (99.9/0.1, v/v) as the mobile phase. The monitoring wavelength was 
215.7 nm. 
 
3.3.6 Epoxidation of trans-β-ethylstyrene catalyzed by Wt CPO and H105A 
The enantioseparation of trans-β-ethylstyrene oxide catalyzed by Wt CPO and the 
H105A mutant were studied (Fig 3.22 and 3.23). The elution order of the epoxidation 
products for this reaction was that the (R)-enantiomer preceded the (S)-enantiomer. The 
resolution factor Rs, calculated for Wt CPO, was 2.88 and for the H105A mutant was 
2.57. The retention factors k1’ and k2’ for Wt CPO were 2.31 and 5.01, and for the  
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Fig 3.22 Enantioselective separation of trans-β-ethylstyrene oxide formed in catalysis by 
Wt CPO on Whelk-O 1 column at 4 ºC using n-hexane/ethanol (99.9/0.1, v/v) as the 
mobile phase. The monitoring wavelength was 218.0 nm. 
 
 
Fig 3.23 Enantioselective separation of trans-β-ethylstyrene oxide formed in catalysis by 
H105A on Whelk-O 1 column at 4 ºC using n-hexane/ethanol (99.9/0.1, v/v) as the 
mobile phase. The monitoring wavelength was 218.0 nm. 
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H105A mutant they were 2.41 and 5.31, respectively. The separation factor α for Wt 
CPO was 2.17 and for the H105A mutant was 2.20. The ee value for Wt CPO was 
13.02%. However, the H105A mutant catalyzed reaction gave 33.56% ee. Therefore, 
similar to the result of trans-β-ethylstyrene epoxidation, the H105A mutant allowed the 
trans-β-ethylstyrene to orient at the heme center and increased the enantioselectivity for 
this substrate compared to wild-type chloroperoxidase. 
3.3.7 Epoxidation of trans-β-propylstyrene catalyzed by Wt CPO and H105A  
 
The enantioseparation of trans-β-propylstyrene oxide by Wt CPO and the H105A 
mutant were studied (Fig 3.24 and 3.25). The elution order of epoxidation products for 
this reaction was that the (R)-enantiomer preceded the (S)-enantiomer. The resolution 
factor Rs calculated for Wt CPO was 3.76 and for the H105A mutant was 3.34. The 
retention factors k1’ and k2’ for Wt CPO were 4.60 and 8.20, and for the H105A mutant 
they were 4.52 and 8.23, respectively. The separation factor α for Wt CPO was 1.79 and 
for the H105A mutant was 1.82. The ee value for Wt CPO was 5.66%. However, the 
H105A mutant catalyzed reaction gave 44.14% of the ee value. The result of the 
enantioselective epoxidation was amazing because it indicated that the H105A mutant 
allowed trans-β-propylstyrene, which was a bulky substrate, to position at the heme 
center to facilitate the epoxidation reactions and showed increased enantioselectivity 
compared to wild-type chloroperoxidase. Among several CPO mutants, the H105A 
mutant was the only one to catalyze the bulky styrene derivatives with good yield and 
great enantioselectivity. Therefore, the H105A mutant has a significant potential for 
industrial applications. 
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Fig 3.24 Enantioselective separation of trans-β-propylstyrene oxide formed in catalysis 
by Wt CPO on Whelk-O 1 column at the room temperature using pure hexane as the 
mobile phase. The monitoring wavelength was 218.0nm. 
 
 
Fig 3.25 Enantioselective separation of trans-β-propylstyrene oxide formed in catalysis 
by H105A on Whelk-O 1 column at the room temperature using pure hexane as the 
mobile phase. The monitoring wavelength was 218.0nm. 
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3.3.8 Epoxidation of styrene catalyzed by Wt CPO and the N74Q mutant 
The epoxidation products of styrene catalyzed by Wt CPO and the N74Q mutant 
were separated and identified using HPLC after comparing the retention times of the 
products with the pure standards (Fig 3.26 and 3.27). The resolution factor Rs calculated 
for Wt CPO was 1.64 and for the N74Q mutant was 1.67. The retention factors k1’ and k2’ 
for Wt CPO were 3.29 and 4.43, and for the N74Q mutant they were 3.29 and 4.40, 
respectively. The separation factor α for Wt CPO was 1.35 and for the N74Q mutant was 
1.33. The ee value for Wt CPO was 49.74%. The N74Q mutant catalyzed reaction gave 
1.94% of the ee value, which was quite different from the wild-type chloroperoxidase. 
Therefore, the mutation of the N74 amino acid changed the enantioselectivity for styrene 
substrates.  
3.3.9 Epoxidation of cis-β-methylstyrene by Wt CPO and the N74Q mutant 
The epoxidation products of cis-β-methylstyrene catalyzed by Wt CPO and the 
N74Q mutant were separated and studied by HPLC (Fig 3.28 and 3.29). Wild- type 
chloroperoxidase-catalyzed epoxidation of cis-β-methylstyrene had only one product, 
which was (1S, 2R)-enantiomer. However, the N74Q mutant catalyzed reaction gave the 
unspecified byproduct. The resolution factor Rs calculated for the N74Q mutant was 
0.614. The retention factors k1’ and k2’ for the N74Q mutant were 6.12 and 7.12, 
respectively. The separation factor α for the N74Q mutant was 1.16. The ee value of the 
N74Q mutant was 14.12%, which indicated that this mutation caused partial loss of the 
enantioselectivity for cis-β-methylstyrene. 
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Fig 3.26 Enantioselective separation of styrene oxide formed in catalysis by Wt CPO on 
Whelk-O 1 column at the room temperature using n-hexane/ethanol (99.8/0.2, v/v) as the 
mobile phase. The monitoring wavelength was 215.7 nm. 
 
 
Fig 3.27 Enantioselective separation of styrene oxide formed in catalysis by the N74Q 
mutant on Whelk-O 1 column at the room temperature using n-hexane/ethanol (99.8/0.2, 
v/v) as the mobile phase. The monitoring wavelength was 215.7 nm. 
 
AU
0.00
0.50
1.00
1.50
2.00
2.50
3.00
Minutes
10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
AU
0.00
0.50
1.00
1.50
2.00
2.50
3.00
Minutes
10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
84 
 
 
Fig 3.28 Enantioselective separation of cis-β-methylstyrene oxide formed in catalysis by 
Wt CPO on Whelk-O 1 column at 4 ºC using pure hexane as the mobile phase. The 
monitoring wavelength was 215.7 nm. 
 
 
Fig 3.29 Enantioselective separation of cis-β-methylstyrene oxide formed in catalysis by 
the N74Q mutant on Whelk-O 1 column at 4 ºC using pure hexane as the mobile phase. 
The monitoring wavelength was 215.7 nm. 
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3.3.10 Epoxidation of trans-β-methylstyrene by Wt CPO and the N74Q mutant 
The epoxidation products of trans-β-methylstyrene by Wt CPO and the N74Q mutant 
were separated and identified using HPLC by comparing the retention times of the 
products with the pure standards (Fig 3.30 and 3.31). The elution order of epoxidation 
products for this reaction was that the (1R, 2R)-enantiomer preceded the (1S, 2S)-
enantiomer. The resolution factor Rs calculated for Wt CPO was 3.76 and for the N74Q 
mutant was 3.95. The retention factors k1’ and k2’ for the products of Wt CPO-catalyzed 
epoxidation were 3.32 and 5.86, and for the N74Q mutant they were 3.34 and 5.87, 
respectively. The separation factor α for Wt CPO was 1.76 and for the N74Q mutant was 
1.75. The ee value for Wt CPO was 2.1%. However, the N74Q mutant catalyzed reaction 
gave 58.1% ee.  
 
Fig 3.30 Enantioselective separation of trans-β-methylstyrene oxide formed in catalysis 
by Wt CPO on Whelk-O 1 column at the room temperature using n-hexane/ethanol 
(99.8/0.2, v/v) as the mobile phase. The monitoring wavelength was 215.7 nm. 
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Fig 3.31 Enantioselective separation of trans-β-methylstyrene oxide formed in catalysis 
by the N74Q mutant on Whelk-O 1 column at the room temperature using n-
hexane/ethanol (99.8/0.2, v/v) as the mobile phase. The monitoring wavelength was 
215.7 nm. 
 
3.3.11 Epoxidation of trans-β-ethylstyrene by Wt CPO and the N74Q mutant 
The enantioseparation of trans-β-ethylstyrene oxide by Wt CPO and the N74Q 
mutant were studied (Fig 3.32 and 3.33). The elution order of epoxidation products for 
this reaction was that the (R)-enantiomer preceded the (S)-enantiomer. The resolution 
factor Rs calculated for Wt CPO was 3.62 and for the N74Q mutant was 3.93. The 
retention factors k1’ and k2’ for Wt CPO were 4.08 and 8.80, and for the N74Q mutant 
they were 4.29 and 9.42, respectively. The separation factor α for Wt CPO was 2.16 and 
for the N74Q mutant was 2.19. The ee value for Wt CPO was 14.34%.  
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Fig 3.32 Enantioselective separation of trans-β-ethylstyrene oxide formed in catalysis by 
Wt CPO on Whelk-O 1 column at 4 ºC using n-hexane/ethanol (99.95/0.05, v/v) as the 
mobile phase. The monitoring wavelength was 218.0 nm. 
 
 
Fig 3.33 Enantioselective separation of trans-β-ethylstyrene oxide formed in catalysis by 
N74Q on Whelk-O 1 column at 4 ºC using n-hexane/ethanol (99.95/0.05, v/v) as the 
mobile phase. The monitoring wavelength was 218.0 nm. 
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Fig 3.34 Enantioselective separation of trans-β-propylstyrene oxide formed in catalysis 
by Wt CPO on Whelk-O 1 column at the room temperature using pure hexane as the 
mobile phase. The monitoring wavelength was 218.0nm. 
 
 
Fig 3.35 Enantioselective separation of trans-β-propylstyrene oxide formed in catalysis 
by N74Q on Whelk-O 1 column at the room temperature using pure hexane as the mobile 
phase. The monitoring wavelength was 218nm. 
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However, the N74Q mutant catalyzed reaction gave 41.52% as the ee value. 
Therefore, similar to the result of trans-β-ethylstyrene epoxidation, the N74Q mutant 
allowed trans-β-ethylstyrene to position at the heme center and enhanced the 
enantioselectivity for this substrate compared to that of the wild-type chloroperoxidase. 
3.3.12 Epoxidation of trans-β-propylstyrene catalyzed by Wt CPO and N74Q 
 
The enantioseparation of trans-β-propylstyrene oxide by Wt CPO and the N74Q 
mutant were carried out to study the expoxidation of long-side-chain styrene derivatives 
by the N74Q mutant (Fig 3.34 and 3.35). The elution order of epoxidation products for 
this reaction was that the (R)-enantiomer preceded the (S)-enantiomer. The resolution 
factor Rs calculated for Wt CPO was 3.76 and for the N74Q mutant was 2.75. The 
retention factors k1’ and k2’ for Wt CPO were 4.60 and 8.20, and for the N74Q mutant 
they were 4.52 and 8.20, respectively. The separation factor α for Wt CPO was 1.79 and 
for the N74Q mutant was 1.82. The ee value for Wt CPO was 5.66%. However, the 
N74Q mutant catalyzed reaction gave 12.12% ee. The epoxidation result indicated that 
the N74Q mutant had similar enantioselectivity for bulky substrates compared to wild-
type chloroperoxidase.  
3.4 Discussion 
In the hemoprotein family, CPO and cytochrome P450 share many similar properties, 
such as using cysteine as the proximal ligand (Ortiz de Montellano, 1995; 
Sundaramoorthy et al., 1995). It has been reported that titration of CPO to pH values 
greater than 7.0 can induce a rapid transition to form a stable but inactive protein 
(Hollenberg & Hager, 1973). The alkaline form of ferric CPO can result in a red shift in 
the Soret absorbance from 400 to 420 nm, and is usually named C420. Even the Soret 
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absorption band of the ferrous CPO-CO complex can be shifted from 446 to 420 nm, 
which is similar with inactivated cytochrome P420 (Hollenberg & Hager, 1973; Imai & 
Soto, 1967; Yu & Gunsalus, 1974). Some results indicate that the coordination sphere of 
C420 may be analogous to P420 (Martinis et al., 1996). 
Ferric CPO is very stable at a lower pH, but when the solution becomes basic, it can 
readily convert to a stable but inactive alkaline form. It has been reported that the pKa for 
the alkaline transition is 7.5, which is also confirmed by my reasearch. The convertion of 
the ferric CPO in the alkaline condition may be caused by the interaction of an ionizable 
residue with the heme iron. The transition from CPO to C420 may suggest the partial 
breakage of proximal thiolate ligation and a mixture of coordination structures. In the 
CPO structure, His 105 is hydrogen-bonded to Glu 183 in the heme distal pocket and may 
be responsible for this transition. 
In my study, site-directed mutagenesis of His 105 residue was carried out and 
characteristics of the H105A mutant were explored. When the distal histidine was 
replaced, the spectrum of H105A in the C420 form was quite different compared to those 
of Wt CPO and recombinant chloroperoxidase. The ferrous Wt CPO and rCPO were 
high-spin, thiolate-ligated heme proteins. When they were converted to C420, low-spin 
state forms were generated and this process was indicative of the binding of the 
additional ligand to the heme iron to form a six coordinated compound. However, the 
result showed that the ferrous C420 form of Wt CPO or rCPO partially lost the thiolate 
ligand in the proximal site because the ferrous low-spin, thiolate-ligated heme complexes 
would generate the Soret peak at approximately 445 nm (Dawson et al., 1983) compared 
to the 425-nm Soret band exhibited by ferrous C420. The difference in the spectra 
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indicated that there was partial imidazole ligation in the ferrous C420. The spectra of the 
ferrous H105A mutant, which exhibited the decreasing Soret peaks at 445 nm instead of 
425 nm, confirmed this conclusion because there was no histidine in the distal site to 
carry out the partial ligand switch. Histidine 105 can form hydrogen bonds with nearby 
amino acids, therefore this residue is very important to protein stability. 
Ferrous C420 can readily bind small exogenous ligands, such as carbon monoxide 
(Hollenberg 1973). The Soret abosrbance of CPO-CO complex at 445 nm is typical for 
ferrous, low-spin, thiolate-ligated heme complexes. The alkaline specta of the ferrous 
CPO-CO complex were blue shifted to 420 nm, which indicated that ferrous-CO C420 
was not thiolate-ligated. There was no shift in the H105A mutant complex, which further 
confirmed the histidine and cysteine switching hypothesis. Actually a mixed population 
of thiolate-bound and imidazole-bound coordination structures may explain these results, 
as found in P420 (Wells et al., 1992; Martinis et al., 1996). The transition to C420 can 
cause distal and proximal switch at the heme center. The presence of a histidine in the 
sixth axial site may cause a spin state transition and prevent the binding of other 
substrates. 
To explore the enantioselectivity of the H105A mutant, styrene, cis-β-methylstyrene, 
trans-β-methylstyrene, trans-β-ethylstyrene and trans-β-propylstyrene were selected to 
react with Wt CPO and its mutants. The Wt CPO was very effective in catalyzing the 
epoxidation of styrene and cis-β-methylstyrene with high yield and ee values. However, 
the epoxidation of trans-β-methylstyrene, trans-β-ethylstyrene and trans-β-propylstyrene 
exhibited low yield and ee values, especially when the substrates had long side chains. 
These results can be explained by the restricted channel and structure of the CPO heme 
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pocket. Therefore, the good yield and ee values for epoxidation of styrene and cis-β-
methylstyrene were a result of their proper fit in the heme pocket. Bulky substrates with 
long side chains were not easy to enter and properly orient at the active center. The 
H105A and N74Q mutants were not good at catalyzing styrene and cis-β-methylstyrene, 
However, their catalyzed epoxidation of trans-β-methylstyrene and trans-β-ethylstyrene 
showed a dramatic increase in both yield and enantioselectivity. Amazingly, the H105A 
mutant can catalyze the bulky substrate trans-β-propylstyrene with more than 50% ee. 
As mentioned in the introduction part, His105 is located in the distal pocket and can 
form a hydrogen bond with Glu183. When this amino acid was replaced by a small and 
nonpolar alanine, it would open more space above the heme center and allow more bulky 
substrates to access the heme pocket and therefore get catalyzed by the enzyme. These 
results gave H105A mutant a great potential for the industrial applications of CPO to 
catalyze some specific bulky styrene derivatives. 
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CHAPTER IV 
EXPRESSION, PURIFICATION AND NMR STUDIES OF DEUTERATED CPO 
4.1 Introduction 
4.1.1 Background 
Many chemical and spectroscopic techniques are now available for structural 
characterization of hemoproteins (Finzel 1984; Frew 1984; Banci 1992; Boddupalli 1992; 
Hasemann 1995; Kuhnel 2006). Among them, NMR spectroscopy is a most powerful 
method for high-resolution structural characterization of metalloenzymes (Wang 2003). 
However, making complete heme proton assignments for CPO has been difficult and the 
proper assignment is important because the heme is the catalytic unit, which determines 
the diversity of enzyme’s functions. Only about half of the heme protons have been 
correctly assigned, and this fact has compromised all NMR attempts to unambiguously 
study the active site solution chemistry of this enzyme (Wang, Tachikawa et al. 2003). 
For example, incorrect heme proton assignments can lead to incorrect assignments of 
heme pocket amino acid protons and questionable conclusions about active site chemistry. 
So the first step in the present effort is to achieve unambiguous and complete heme 
proton assignments, which will subsequently lead to hyperfine resonance assignments of 
amino acids at the heme active center. The complete assignment of heme protons will 
provide the necessary foundation for expanding solution studies of active site dynamics. 
4.1.2 Aim of the study 
There are several objectives for this project. One of my goals is to determine if any 
deuterated forms of CPO can be produced in the marine fungus C. fumago because the 
fungi expression system has never been studied to secrete deuterated hemoproteins. I also 
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want to determine whether, if successfully expressed and purified, these enzymes would 
be stable and their chemical properties varied from those of the corresponding wild-type 
chloroperoxidase. A prime motivation for producing these deuterated enzymes is to 
obtain more or a complete set of unambiguous heme proton resonance assignments using 
the low-spin, CN-ligated forms. Another purpose of this research is to assign the protons 
of important amino acids in the distal and proximal region of heme active center.  
To make complete heme proton assignments, special [dCPO(heme)] was produced 
using 90% of deuterated growth medium with excess heme precursors and [dCPO(Phe)] 
was grown in the same highly deuterated medium that had been supplemented with 
excess natural phenylalanine. NMR spectroscopy was performed for high-resolution 
structural characterization of [dCPO(heme)] and [dCPO(Phe)] to achieve unambiguous 
and complete heme proton assignments, which also allowed important amino acids close 
to the heme active center to be assesed. 
4.2 Materials and Methods 
4.2.1 Materials 
My sample of Caldariomyces fumago was purchased from American Type Culture 
Collection (ATCC, Manassas, VA). De-ionized water for all the experiments was 
prepared freshly by Milli-Q Biocel (Millipore, Billerica, MA). Deuterium oxide was 
purchased from Cambridge Isotope Laboratories (Andover, MA). Besides, all chemicals 
and reagents were purchased from either Sigma-Aldrich, St. Louis, MO or Fisher 
Scientific, Pittsburg, PA. 
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4.2.2 Expression of deuterated CPO in C. fumago 
The C. fumago cells from ATCC were grown on the Potato Dextrose Agar (PDA) 
plates for a week at 25 degrees Celsius. The clones from the plates were transferred into 
50 mL of fructose peptone salts (FPS) culturing media with 100 mg/L antibiotic 
carbenicillin. The Omni TH115 homogenizer was used to separate the mycelium for 30 
secs with 10 secs interval. After culturing at 250 rpm and 21.5 °C for 7 days, the 
mycelium was homogenized again and centrifuged at 3000 rpm for 10 minutes. The fungi 
were then exported to the deuterated medium and were grown in different solutions 
prepared with 25%, 50% and 70% of D2O to produce deuterated CPO (dCPO). 
Deuterated CPO, supplemented with excess native heme precursor [dCPO(heme)] and 
phenylalanine (at natural hydrogen isotope abundance) [dCPO(Phe)], were grown in 1 L 
baffled culture flasks containing 90% of deuterated oxide for additional 4 weeks at 21.5 
degrees Celsius. The yield of dCPO was examined daily by the MCD assay until the 
reaction rate reached the maxium level. Then the culturing medium was collected via 
filtering through Mirocloth and ready for purification steps. 
4.2.3 Purification of dCPO 
Acetone precipitation, ion exchange and gel filtration chromatography were used to 
purify the deuterated protein after the collection of the crude media. The supernatant of 
culturing medium was precipitated in 25% of acetone to exclude the pigment and sugar, 
followed by the second 75% of acetone precipitation to collect the deuterated protein. 
About 100 mL of samples were collected by dissolving the precipitate into 50 mM 
potassium phosphate buffer at pH 5.9 and dialyzed for 24 hrs with at least one buffer 
exchange. For protein purification, DEAE Sepharose fast flow column (Amersham, 2.6 × 
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20 cm) and Sephadex G-75 column (Amersham, 2.6 × 100 cm) were applied. Ion 
exchange chromatography was used to separate the desired protein from others by ionic 
strength gradient difference (0-0.5 M NaCl) in 50 mM potassium phosphate buffer at pH 
5.9. All these experiments were carried out at 4 ºC to keep the mutant protein stable. 
Reinheitzahl (Rz) value was employed to examine the purity of enzymes and those of 
which higher than 0.9 was collected and condensed by using Centriprep-YM30 (Amincon) 
for further kinetic study. The yield of dCPO was 20 mg/L with Rz value 1.2 for 70%. The 
total yield of 90% dCPO (heme) was 10 mg/L with Rz value 0.9. The yield of purified 90% 
dCPO (Phe) was 10 mg/L with Rz value 1.1. 
4.2.4 Sample preparation for NMR study 
Protein samples for proton NMR experiments were concentrated to 0.5 mM by using 
Millipore Centricon YM30 filter in 95% of H2O, 5% of D2O or D2O buffer solutions 
containing 50 mM potassium phosphate at pH 5.9. Samples were prepared by isotope 
exchange for at least five times. The cyanide adducts of the protein were prepared by the 
addition of excess cyanide from a freshly made 1 M stock solution in 99.9% of D2O 
buffer. 
4.2.5 NMR Spectroscopy 
The NMR experiments were conducted with a Bruker Avance 600 spectrometer 
(Ultrashield) at the proton frequency of 600-MHz at room temperature. Observed proton 
chemical shifts were referred to the residual HDO peak at 4.76 ppm at 25 °C to match the 
previous NMR studies. The 1D proton NMR spectra of the high-spin ferric deuterated 
enzyme was studied at 125 kHz spectral width, 16k data points and 15 per sec repetition 
rate. To receive the better results on the basis of the property of high-spin heme, about 
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20k to 60k scans were collected. To prepare the low-spin cyanide complex, about 10 mM 
freshly made KCN was added into the high-spin protein sample. The proton NMR 
experiment of the low-spin ferric deuterated enzyme was carried out at 62.5 kHz spectral 
width, 4k data points and 0.2 per sec repetition rate. For the fast relaxing broad proton 
signals, 125 kHz spectral width, 2k data points and 10 ms repetition rate was also 
employed. 
The relaxation time (T1) of the hyperfine shifted protein in the deuterated samples 
was determined by investigating the inversion-recovery pulse sequence. Normally a 90° 
pulse of 7.54 μs with 3.2 per sec repetition rate was used. T1 value was calculated from 
the null point (τ) by using the equation T1 = τ/ln2. 
The NOESY and COSY two dimentional NMR spectra of deuterated CPO cyanide 
complex were collected at 600-MHz spectrometer 25 degrees Celsius. A single 90° pulse 
was used to get the maximum of the bandwidth. In the F1 dimension, 256 experiments 
with 400 scans were recorded. In the F2 dimension, 80 ppm spectral width, 5 per sec 
repetition rate, 10 ms mixing time, 2000 experiments with 4k data points was collected. 
The parameters of COSY experiments were very similar to NOESY. 
4.3 Results 
4.3.1 Gel electrophoresis of 70% dCPO 
Gel electrophoresis was a widely used method to estimate the molecular weight of 
the polypeptides and proteins. Wild-type CPO contained about 2000 non-exchangeable 
protons, which could be replaced by the deuterium atoms in the deuterated form of 
chloroperoxidase. Wild-type CPO was a heavily glycosylated enzyme with 18% of sugar 
content and contained two isomers, which showed two close bands in gel electrophoresis 
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(Fig 4.1). The deuterated CPO had much less glycosylation and isomerization compared 
to Wt CPO on the basis of the infertile culturing enviroment. Therefore the SDS-PAGE 
result showed that the molecular weight of 70% deuterated CPO was very similar to that 
of Wt CPO and there was essentially no weak band for the isomers. 
 
 
Fig 4.1 The 15% SDS-PAGE result for Wt CPO and dCPO. Lane 1 was the protein 
marker. Lane 2 was purified Wt CPO protein sample. Lane 3 was purified 70% of dCPO 
sample.  
 
4.3.2 UV-Visible spectra of 70% dCPO and CO binding complex 
The UV-Visible Soret absorption spectra of the heme proteins could convey 
significant information about the structure and the coordination state of the active sites 
(Nakajima 1985). The equilibrium absorption spectra of the ferric species of the 
deuterated CPO were measured in 50 mM phosphate buffer at pH 5.9 (Fig 4.2). The Wt 
CPO had strong Soret absorption bands in the 398 nm spectral region that arised from π-
π* electronic transitions. The minor peaks of Wt CPO were located at 515, 539, and 650 
nm. Compared to that, the major peak of dCPO, shown in red, was shifted to 406 nm, and 
its minor peaks were also shifted to 515, 540 and 650 nm. These minor shifts may be 
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caused by replacement of H with D at the backbone of the enzyme. On the basis of the 
little shift of the Soret peak, it was concluded that deuteration did not cause large effects 
at the active center.  
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Fig 4.2 Absorption spectra of the purified Wt CPO and dCPO in 50 mM potassium 
phosphate buffer at pH 5.9. 
 
4.3.3 UV-Vis spectroscopic study of dCPO-CO binding complex 
The binding of dCPO with CO was also detected using UV-Vis spectroscopy. The 
carbon monoxide binding method was a classic assay for cytochrome P450s (Lewis 1996; 
Auclair 2001). The CO adducts of thiolate-ligated system showed a well-known 
absorption band near 450 nm, while for the histidine-ligated systems, that band was blue-
shifted to 420 nm. In Wt CPO, the formation of the ferrous-CO state completely shifted 
the major peak from 398 to 445 nm. After reducing the central iron of dCPO from ferric 
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to CO bound ferrous form, the major peak was partially shifted from 404 nm to 442 nm, 
which indicated that the proximal ligand in the deuterated CPO was a cysteine (Fig 4.3). 
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Fig 4.3 UV-Visible spectra of the ferrous-CO complex of Wt CPO and dCPO in 50 mM 
potassium phosphate buffer at pH=5.9. 
 
4.3.4 Cyanide binding properties of 70% dCPO 
The strong binding ligand cyanide was widely used to evaluate the affinity of CPO 
for a sixth axial ligand. The UV-Vis spectra of the binding complex were obtained. 
Cyanide had the ability to convert the high-spin iron state to the low-spin form, therefore 
the binding of cyanide to CPO resulted in the shift of the Soret peak. In Wt CPO, the 
Soret peak was shifted from 398 to 439 nanometers. Compared with that, the spectral 
change in 70% dCPO, which occurred upon addition of cyanide, was that the Soret peak 
was also shifted to 439 nanometers. The spectra of the cyanide binding complexes 
confirmed that the environment of the heme active center did not change during the 
deuteration.  
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Fig 4.4 UV-Visible spectra of the cyanide complexes with dCPO in 50 mM potassium 
cyanide alkaline solution. 
 
4.3.5 1H NMR spectra of 70% dCPO and Wt CPO cyanide complex 
The proton NMR experiment of the native ferric high-spin dCPO was carried out 
using 600-MHz NMR spectrometer. Because of the high-spin nature of dCPO, 
considerably broad resonances were observed in the NMR spectra that provided only 
limited information about the structural properties of the enzyme. Therefore I focused on 
the NMR spectral properties of the cyanide-bound, ferric low-spin derivative of 
deuterated chloroperoxidase. The cyanide-bound deuterated CPO could provide much 
more information about the electronic, magnetic, and molecular structural properties of 
the heme pocket as compared to the native, high-spin resting forms.  
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Fig 4.5 600-MHz 1H NMR spectra of the low-spin cyanide complexes of 70% dCPO 
(lower trace) and Wt CPO (top trace) in 95% H2O. The spectrum was collected at 298 K 
in 50 mM phosphate buffer at pH 5.9.  
 
The spectral features of the dCPO-CN complex displayed a high degree of similarity 
to that of the Wt CPO-CN complex. The two intense signals with the integrated 
intensities of three protons each in the downfield region were typical of heme methyl 
groups. They have been assigned to the two heme methyls (8- and 3-CH3). Other 
resonances with intensities of one proton each in the downfield region represented 
protons from other heme substitutes and those from amino acid residues in the proximal 
and distal heme pocket (Wang, Tachikawa et al. 2003). The dCPO-CN complex gave a 
much weaker intensity of proton signals on 1H NMR spectra than that of the native CPO-
CN complex. In Fig 4.5, two spectra were plotted at vertical expansions so that the tallest 
resonances of heme methyl groups have the identical heights. The similarity in these 
spectra emphasized that the essentially identical nature of the heme active site and 
reinforced the concept of structurally and functionally intact active site for the deuterated 
enzymes. 
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4.3.6 2H NMR spectra of 70% dCPO-CN complex 
 
 
Fig 4.6 600-MHz 2H NMR spectra of the low-spin cyanide complexes of 70% dCPO in 
95% H2O. The spectrum is collected at 298 K in 50 mM phosphate buffer at pH 5.9.  
 
Deuterium NMR has a range of chemical shift similar to proton NMR but with poor 
resolution. It can be used to verify the effectiveness of deuteration. In Fig 4.6, we could 
find the two weak peaks at 23.6 ppm and 20.4 ppm, which had been assigned to 8-CH3 
and 3-CH3 on the heme, respectively. The increased peak intensity indicated the 
successful replacement of the backbone protons by deuterium atoms. 
4.3.7 1H NOESY spectra of 70% dCPO-CN 
The NOESY spectrum of dCPO-CN collected in the D2O buffer with a mixing time 
of 35 ms was shown in Fig 4.7. The peaks in the marked area were identical and 
confirmed with the NOESY spectra of nCPO-CN. However, there were half of peaks 
missing from the dCPO-CN spectra, compared to those of nCPO-CN. It was reasonable 
66.2 
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because most protons on the backbone of the polypeptide chains had been replaced by 
deuterium atoms. Therefore, the signals became weak, even invisible in the deuterated 
spectra. 
 
Fig 4.7 600-MHz 1H NOESY spectrum of 0.5 mM 70% dCPO-CN in 95% H2O taken 
with a mixing time of 35 ms.  
 
The deuterated forms of CPO could be produced in marine fungus C. fumago with 
reasonable yield and deuteration did not significantly alter CPO’s reactivity or 1H NMR 
spectral pattern. Relatively high deuteration has been achieved by examining the 2H and 
NOESY NMR spectra. As an example of potential NMR uses, dCPO containing selected 
amino acid with natural hydrogen isotope abundance could be used to achieve complete 
stereospecific 1H resonance assignments for hyperfine-shifted protons of the heme or 
amino acids close to the heme center. 
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4.3.8 1H NMR spectra of 90% dCPO (heme)-CN and nCPO-CN 
 
 
 
Fig 4.8 600-MHz 1H NMR spectra of the low-spin cyanide complexes of 90% dCPO 
(heme) (top trace) and nCPO (lower trace) in D2O. The spectra were collected at 298 K in 
50 mM phosphate buffer at pH 5.9.  
 
Comparison of 1H NMR spectra of dCPO-CN and dCPO(heme)-CN complex was 
shown in Fig 4.8. The results were plotted so that in each spectrum the protein resonance 
of methyl group had the same intensity. Prominently reduced intensity at 14.1 ppm in 
dCPO(heme)-CN was the resonance previously assigned to the proton of 7-Hα. The 
missing resonance at 17.4 ppm had not been assigned yet, but it was definitely not from 
the heme. Since the T1 value of this resonance was only 6 ms, it may be assigned to the 
proton of a certain amino acid, which was in close distance to the heme iron. 
 
106 
 
4.3.9 NOE connectivity between several resonances 
The assignment of the hyperfine shifted signals for the dCPO(heme)-CN complex 
was examined through one dimensional NOE measurement. In Fig 4.9, the NOE 
 
 
Fig 4.9 600-MHz 1H NMR saturation transfer difference spectra of 90% dCPO (heme)-
CN generated by subtracting the reference spectrum. Arrows indicate position of pulses. 
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connectivities proved the validity of the previous NOE assignment (Wang, Tachikawa et 
al. 2003). The heme methyl resonance at 24.0 ppm showed the weak NOEs to the peak at 
11.6 ppm. The other set of the heme methyl signals at 20.4 ppm produced an extremely 
weak NOE to the resonance at 7.37 ppm and the weak NOEs to signals at -2.7 ppm and -
4.4 ppm. The last two signals were assigned to 4-Hβtrans and 4-Hβcis, respectively. 
However, resonances of 3-CH3, 4-Hβtrans and 4-Hβcis showed the weak NOEs to the peak 
at 7.37 ppm, which had not been assigned before. 
4.3.10 Assignment of the proton with the shift at 17.4 ppm 
As mentioned before, the peak with the chemical shift of 17.4 ppm had not been 
assigned yet. On the basis of the results of the 1H NMR spectra, we could conclude that 
this resonance was definitely not from the heme protons. Since the T1 value of this 
resonance was only 6 ms, it may be assigned to the proton of certain amino acid, which 
was very close to the heme iron. Fig 4.10 showed all the amino acids in the distance of 5 
Å to the heme iron.  
Even though the 10-0 ppm region in the 1D 1H spectrum of the nCPO-CN complex 
seemed overlapped, resolution of deuterated sample was much higher by using heme at 
the natural isotope abandance, which could lead to the unambiguous connectivities and 
assignments. The NOE results of the deuterated sample gave more information in the 
diamagnetic region compared to those of the native CPO-CN complex. Since resonances 
of 3-CH3, 4-Hβtrans and 4-Hβcis all gave weak NOEs to the peak at 7.37 ppm, this 
resonance could probably be assigned to a proton from a nearby amino acid since no 
protons except 4-Hα proton from the heme can give such a NOE pattern. The 
unambiguous and complete heme proton assignment was very important because it could 
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lead to hyperfine resonance assignments of the active site amino acids, and provided the 
necessary basis for expanding the solution studies of the active site dynamics.  
 
Fig 4.10 Structure of amino acids around the heme and the distance to the central iron are 
shown (PDB: 1CPO). 
 
4.3.11 UV-Vis spectra of nCPO, 70% dCPO and 90% dCPO (Phe) 
The characteristic Soret absorption bands can convey significant information about 
the active site structure and the coordination state of heme-containding proteins. Fig 4.11 
displayed the equilibrium absorption spectra of the ferric species of the native CPO, 
deuterated CPO and deuterated CPO with a native phenylalanine. The native CPO has 
strong Soret absorption bands at 398 nanometers. The minor peaks were located at 515, 
539, and 650 nanometers. Compared to those of nCPO, we find that there were only 
minor Soret peak shifts in the spectra of dCPO and dCPO(Phe), and the minor peaks 
exhibited the same pattern.  
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Fig 4.11 Absorption spectra of the purified Wt CPO and dCPO(Phe) in 50 mM potassium 
phosphate buffer at pH 5.9. 
 
4.3.12 1H NMR spectra of 90% dCPO(Phe) and Wt CPO 
The comparison of 1H NMR spectra of the dCPO-CN and dCPO(Phe)-CN complex 
was shown in Fig 4.12. The results were plotted so that in each spectrum the protein 
resonance of methyl groups had the same height. Compared with the nCPO-CN complex, 
the peak intensities at 11.9 ppm, 10.5 ppm and 9.9 ppm increased remarkably. Since the 
deuterated CPO was cultured with the excess of Phe at natural hydrogen isotope 
abundance, the increased peak signals should derive from the Phe 57, Phe 103 and Phe 
186 residues, which were close to the heme iron. 
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Fig 4.12 600-MHz 1H NMR spectra of the low-spin cyanide complexes of 90% 
dCPO(Phe) (top trace) and Wt CPO (lower trace) in D2O. The spectra were collected at 
298 K in 50 mM phosphate buffer at pH 5.9.  
 
4.3.13 T1 measurement 
 
Table 4.1 Proton NMR parameters and assignments of paramagnetically shifted 
resonances in dCPO(Phe)-CN at 298 K, in 50 mM phosphate buffer, pH 5.9. 
111 
 
The chemical shifts and the corresponding T1 values predicted from T1ir1d 
programmed experiment were compiled in Table 4.1, along with the reported T1 data. 
The resonances I was interested in, located at 11.9 ppm and 9.9 ppm, had not been 
assigned yet and their T1 values were not reported before. On the basis of this information, 
the distance from these two protons to the heme iron could be predicted to complete the 
proton assignments.  
4.3.14 NOE connectivity of dCPO(Phe)-CN 
 
Fig 4.13 600-MHz 1H NMR saturation transfer difference spectra of 90% dCPO(Phe)-CN 
generated by subtracting the reference spectrum.  
 
The chemical shifts and the corresponding T1 values predicted from T1ir1d 
experiment were compiled in Table 4.1, along with the reported T1 data. The resonances 
we are interested in, shifts at 11.9 ppm and 9.9 ppm, were not assigned yet and their T1 
values were not reported before. On the basis of this information, we could predict the 
distance from these two protons to the heme iron and then complete the assignments.  
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4.3.15 1H NOESY and COSY spectra of 90% dCPO(Phe)-CN 
 
Fig 4.14 600-MHz phase-sensitive 1H spectrum of 0.5mM 90% dCPO(Phe)-CN in 50 
mM phosphate buffer, pH 5.9. 
 
Fig 4.15 600-MHz phase-sensitive 1H COSY spectrum of 0.5 mM 90% dCPO(Phe)-CN 
in 50 mM phosphate buffer, pH 5.9. 
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The clear NOESY connectivities and the results from COSY proved the validity of 
previous NOE resonances observed in one-dimensional NOE experiments and led to the 
proposed assignments for three nonexchangeable hyperfine shifted protons from the Phe 
groups in dCPO(Phe)-CN complex. The correlation between 9.9 ppm and 7.2 ppm in the 
COSY spectra indicated that these resonances were from the same Phe group and the 
shift at 11.9 ppm belonged to another phenylalanine residue. 
4.3.16 Proton assignments of Phe 186 and Phe 103 
In CPO’s genome, there are 18 Phe. Among them, Phe 57, Phe 103 and Phe 186 are 
in the close distance to the heme active center. However, Phe 57 is located in the 
proximal side of heme and does not have the correlation with any other Phe groups, so it 
could not give the NOESY and COSY spectra as mentioned above. Fig 4.16 showed the 
locations of Phe 103 and Phe 186. They were close enough to have the NOE effects and 
both were near the heme center to obtain the chemical shifts inproton NMR spectra. 
 
Fig 4.16 Structure of the heme distal pocket in chloroperoxidase showing the position of 
Phe 186, Phe 103. 
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Table 4.2 showed the predicted distances that were obtained from the T1 values for 
the selected protons according to the relationship ri/rj = [T1i/T1j]1/6 (Thanabal, De Ropp et 
al. 1987). The average distance (6.05 Å) of the three protons of the heme 8-CH3 group to 
the iron was used as a reference for the predictions. The actual distance of the proton in 
question to the heme iron was determined from the crystal coordinates of 
chloroperoxidase (Sundaramoorthy, Terner et al. 1995). Therefore, we could assign the 
shift at 11.9 ppm to Phe 186 and shifts at 9.9 ppm, 7.2 ppm to phenylalanine 103. 
 
Table 4.2 Distances between the heme iron and the protons of Phe 186 and Phe 103. 
4.4 Discussion 
Most of the heme protons in CPO have been assigned and the results are consistent 
with x-ray diffraction studies of the crystal form (Wang 2003). The NOE patterns of 
dCPO(Phe) are consistent with the results reported before from one dimensional study. 
The heme methyl resonances at 24.0 and 23.8 ppm give weak NOEs to peaks at 14.1, 
12.9 and 11.6 ppm and therefore can be assigned to the 5- or 8-CH3 group of the two 
isozymes of CPO. The signals at 20.7 and 20.4 ppm give weak NOEs to resonance at 
14.8, -2.7 and -4.4 ppm, and therefore can be assigned to a nearby methyl group of the 
two isozymes. Since incorporation of natural proton abundance Phe did not change the 
composition of heme active center, this result is also in perfect agreement with the results 
obtained from analysis of the Wt CPO structure. 
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From the 1D proton NMR spectra of dCPO(Phe), apparent increased peak intensity 
at 11.9, 9.9 and 7.2 ppm indicated that they were from the protons of the Phe amino acids 
close to the heme iron. By the incorporation of Phe at natural hydrogen isotope 
abundance, we could assign the protons of Phe 103 and Phe 186 in the distal region of the 
heme active center. On the basis of the relationship between the T1 values of the 
inequivalent protons in noncoordinating groups and their distances to the paramagnetic 
center, it was assumed that heme methyl protons had an average distance of 6.1 Å from 
the heme iron. Therefore, it was reasonable, in the absence of the crystal coordinates of 
CPO, to assign these signals to the heme mesoprotons, because they were the only 
remaining protons close enough to the heme iron to experience the sufficient 
paramagnetic relaxation. In this way, two unknown NMR signals at 9.9 ppm and 7.2 ppm 
had been successfully assigned to the protons of the Phe 103 residue. The shift at11.9 
ppm was misassigned to CH2 of Pro 28 in the previous NMR studies. On the basis of the 
peak intensity and predicted distance, it was considered to be Hε of Phe 186.  
The importance of this research is that it is the first time to culture the deuterated 
heme containing protein in the fungi system with selected amino acids at natural isotope 
abundance. These results lead to the first unambiguous assignments for most of the 
hyperfine-shifted resonances of the ferric low-spin dCPO-CN- complexes. Further studies 
can be carried out to locate the NMR properties of other important amino acid residues. 
This can be achieved by replacing these residues with other amino acids, selectively 
labeling these residues with an NMR active isotope such as 13C or 15N or exchanging the 
deuterated amino acid with natural isotope abundance. 
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NMR study of the deuterated heme-containing proteins is a straightforward method 
that can overcome existing hurdles and allows the complete heme proton assignments. 
Such an approach is potentially applicable to other hemoproteins. 
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APPENDIX A 
Figure A1 Amino acid sequence of full-length of Wt CPO. 
 
1    XEPGSGIGYP YDNNTLPYVA PGPTDSRAPC PALNALANHG YIPHDGRAIS   
51   RETLQNAFLN HMGIANSVIE  LALTNAFVVC  EYVTGSDCGD SLVNLTLLAE 
101 PHAFEHDHSF SRKDYKQGVA NSNDFIDNRN FDAETFQTSL DVVAGKTHFD 
151 YADMNEIRLQ RESLSNELDF PGWFTESKPI QNVESGFIFA LVSDFNLPDN   
201 DENPLVRIDW WKYWFTNESF PYHLGWHPPS  PAREIEFVTS  ASSAVLAASV  
251 TSTPSSLPSG  AIGPGAEAVP  LSFASTMTPF LLATNAPYYA QDPTLGPND 
 
Figure A2 DNA sequence of full-length of Wt CPO (1122bp). 
 
1  a t g t t c t c c a  a g g t c c t t c c  c t t c g t g gg a  gc g g t t g c c g  c c c t c cc t c a  c t c c g t c c g t 
61 caggagcctg  gctccggcat  tggctaccca tacgacaaca acaccctgcc a ta tgtcgcc 
121 ccaggtccta  ccgactc tcg  tgctcc t tgc ccagctc tga  acgctc t tgc  caaccacggt 
181 tacat tcctc  acgatggccg tgccatcagc agggagaccc tccagaacgc t t tcctcaac 
241  caca tgggta  t tgccaac tc  cg tca t tgag  c t tgc tc tga  ccaacgcc t t  cg tcg tc tgc 
301 gagtacgt ta  c tggctccga c tgtggtgac  agcct tgtca  acctgactc t  gctcgccgag 
361 ccccacgctt  tcgagcacga ccactcct tc  tcccgcaagg at tacaagca gggtgtcgcc 
421 aactccaacg act tcatcga caacaggaac  t tcgatgccg agacct tcca gacctctc tg 
481 gatgtcgt tg caggcaagac ccact tcgac tatgccgaca tgaacgagat  ccgcct tcag 
541 cgcgagtccc tc tccaacga gct tgact tc  cccggt tggt  tcaccgagtc  caagccaatc 
601  cagaacgtcg  agtc tggc t t  ca tc t tcgcc  c t tg tc tc tg  ac t tcaacc t  gcccgacaac 
661 gatgagaacc  c tc tggt tcg  ca t tgactgg tggaagtac t  ggt tcaccaa  cgagtcc t tc 
721 ccataccacc tcggctggca ccccccgtct  ccagccaggg agatcgagtt  cgtcacctcc 
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